<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Skin grafting and tissue replacement for treating foot ulcers in people with diabetes - Santema, TB - 2016 | Cochrane Library</title> <meta content="Skin grafting and tissue replacement for treating foot ulcers in people with diabetes - Santema, TB - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011255.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Skin grafting and tissue replacement for treating foot ulcers in people with diabetes - Santema, TB - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011255.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011255.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Skin grafting and tissue replacement for treating foot ulcers in people with diabetes" name="citation_title"/> <meta content="Trientje B Santema" name="citation_author"/> <meta content="Academic Medical Centre at the University of Amsterdam" name="citation_author_institution"/> <meta content="t.b.santema@amc.uva.nl" name="citation_author_email"/> <meta content="Paul PC Poyck" name="citation_author"/> <meta content="Royal Brisbane and Women's Hospital" name="citation_author_institution"/> <meta content="Dirk T Ubbink" name="citation_author"/> <meta content="Academic Medical Center at the University of Amsterdam" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD011255.pub2" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/02/11" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011255.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011255.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011255.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Wound Healing; Amputation, Surgical [statistics &amp; numerical data]; Diabetic Foot [*surgery]; Foot Ulcer [surgery]; Randomized Controlled Trials as Topic; Skin Transplantation [adverse effects, *methods]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011255.pub2&amp;doi=10.1002/14651858.CD011255.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="Xx9QLps0";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011255\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011255\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","ru","hr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011255.pub2",title:"Skin grafting and tissue replacement for treating foot ulcers in people with diabetes",firstPublishedDate:"Feb 11, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Wounds Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xx9QLps0&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011255.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011255.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011255.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011255.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011255.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011255.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011255.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011255.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011255.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011255.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6945 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011255.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/full#CD011255-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/full#CD011255-sec-0097"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/full#CD011255-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/full#CD011255-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/full#CD011255-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/full#CD011255-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/full#CD011255-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/full#CD011255-sec-0091"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/appendices#CD011255-sec-0102"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/table_n/CD011255StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/table_n/CD011255StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Skin grafting and tissue replacement for treating foot ulcers in people with diabetes</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/information#CD011255-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Trientje B Santema</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/information#CD011255-cr-0003">Paul PC Poyck</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011255.pub2/information#CD011255-cr-0004">Dirk T Ubbink</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/information/en#CD011255-sec-0137">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 11 February 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011255.pub2">https://doi.org/10.1002/14651858.CD011255.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011255-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011255-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011255-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011255-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011255-abs-0012">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD011255-abs-0002">繁體中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011255-abs-0001" lang="en"> <section id="CD011255-sec-0001"> <h3 class="title" id="CD011255-sec-0001">Background</h3> <p>Foot ulceration is a major problem in people with diabetes and is the leading cause of hospitalisation and limb amputations. Skin grafts and tissue replacements can be used to reconstruct skin defects for people with diabetic foot ulcers in addition to providing them with standard care. Skin substitutes can consist of bioengineered or artificial skin, autografts (taken from the patient), allografts (taken from another person) or xenografts (taken from animals). </p> </section> <section id="CD011255-sec-0002"> <h3 class="title" id="CD011255-sec-0002">Objectives</h3> <p>To determine the benefits and harms of skin grafting and tissue replacement for treating foot ulcers in people with diabetes. </p> </section> <section id="CD011255-sec-0003"> <h3 class="title" id="CD011255-sec-0003">Search methods</h3> <p>In April 2015 we searched: The Cochrane Wounds Specialised Register; the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library); Ovid MEDLINE; Ovid MEDLINE (In‐Process &amp; Other Non‐Indexed Citations); Ovid EMBASE and EBSCO CINAHL. We also searched clinical trial registries to identify ongoing studies. We did not apply restrictions to language, date of publication or study setting. </p> </section> <section id="CD011255-sec-0004"> <h3 class="title" id="CD011255-sec-0004">Selection criteria</h3> <p>Randomised clinical trials (RCTs) of skin grafts or tissue replacements for treating foot ulcers in people with diabetes. </p> </section> <section id="CD011255-sec-0005"> <h3 class="title" id="CD011255-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data and assessed the quality of the included studies. </p> </section> <section id="CD011255-sec-0006"> <h3 class="title" id="CD011255-sec-0006">Main results</h3> <p>We included seventeen studies with a total of 1655 randomised participants in this review. Risk of bias was variable among studies. Blinding of participants, personnel and outcome assessment was not possible in most trials because of obvious differences between the treatments. The lack of a blinded outcome assessor may have caused detection bias when ulcer healing was assessed. However, possible detection bias is hard to prevent due to the nature of the skin replacement products we assessed, and the fact that they are easily recognisable. Strikingly, nearly all studies (15/17) reported industry involvement; at least one of the authors was connected to a commercial organisation or the study was funded by a commercial organisation. In addition, the funnel plot for assessing risk of bias appeared to be asymmetrical; suggesting that small studies with 'negative' results are less likely to be published. </p> <p>Thirteen of the studies included in this review compared a skin graft or tissue replacement with standard care. Four studies compared two grafts or tissue replacements with each other. When we pooled the results of all the individual studies, the skin grafts and tissue replacement products that were used in the trials increased the healing rate of foot ulcers in patients with diabetes compared to standard care (risk ratio (RR) 1.55, 95% confidence interval (CI) 1.30 to 1.85, <i>low quality of evidence</i>). However, the strength of effect was variable depending on the specific product that was used (e.g. EpiFix® RR 11.08, 95% CI 1.69 to 72.82 and OrCel® RR 1.75, 95% CI 0.61 to 5.05). Based on the four included studies that directly compared two products, no specific type of skin graft or tissue replacement showed a superior effect on ulcer healing over another type of skin graft or tissue replacement. </p> <p>Sixteen of the included studies reported on adverse events in various ways. No study reported a statistically significant difference in the occurrence of adverse events between the intervention and the control group. </p> <p>Only two of the included studies reported on total incidence of lower limb amputations. We found fewer amputations in the experimental group compared with the standard care group when we pooled the results of these two studies, although the absolute risk reduction for amputation was small (RR 0.43, 95% CI 0.23 to 0.81; risk difference (RD) ‐0.06, 95% CI ‐0.10 to ‐0.01, <i>very low quality of evidence</i>). </p> </section> <section id="CD011255-sec-0007"> <h3 class="title" id="CD011255-sec-0007">Authors' conclusions</h3> <p>Based on the studies included in this review, the overall therapeutic effect of skin grafts and tissue replacements used in conjunction with standard care shows an increase in the healing rate of foot ulcers and slightly fewer amputations in people with diabetes compared with standard care alone. However, the data available to us was insufficient for us to draw conclusions on the effectiveness of different types of skin grafts or tissue replacement therapies. In addition, evidence of long term effectiveness is lacking and cost‐effectiveness is uncertain. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011255-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011255-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011255-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011255-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011255-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011255-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011255-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011255-abs-0013">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD011255-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011255-abs-0003" lang="en"> <h3>Skin grafting and tissue replacement for treating foot ulcers in people with diabetes</h3> <p><b>Background</b> </p> <p>Foot ulceration is a major problem in people with diabetes and is the leading cause of hospital admissions and limb amputations. Despite the current variety of strategies available for the treatment of foot ulcers in people with diabetes, not all ulcers heal completely. Additional treatments with skin grafts and tissue replacement products have been developed to help complete wound closure. </p> <p><b>Review question</b> </p> <p>What are the benefits and harms of skin grafting and tissue replacement for treating foot ulcers in people with diabetes? </p> <p><b>What we found</b> </p> <p>We included thirteen randomised studies that compared two types of skin grafts or tissue replacements with standard care and four randomised studies that compared two grafts or tissue replacements with each other. In total 1655 patients were randomised in these seventeen trials. Risk of bias was variable among studies. The biggest drawbacks were the lack of blinding (i.e. patients and investigators were aware who was receiving the experimental therapy and who was receiving the standard therapy), industry involvement and the possibility that small studies were less likely to be published if they reported 'negative' results. Adverse advent rates (harm due to the treatment) varied widely. </p> <p><b>Conclusion</b> </p> <p>Based on the seventeen studies included in this review, skin grafts and tissue replacements, used in conjunction with standard care, increase the healing rate of foot ulcers and lead to slightly fewer amputations in people with diabetes compared with standard care alone. However, evidence of long term effectiveness is lacking and cost‐effectiveness is uncertain. There was not enough evidence for us to be able to recommend a specific type of skin graft or tissue replacement. </p> <p>This plain language summary is up‐to‐date as of 9 April 2015.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011255-sec-0097" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011255-sec-0097"></div> <h3 class="title" id="CD011255-sec-0098">Implications for practice</h3> <section id="CD011255-sec-0098"> <p>Overall, the therapeutic effect of skin grafts and tissue replacements, in conjunction with standard care, shows an increase in the healing rate of foot ulcers and slightly fewer amputations in people with diabetes compared with standard care alone. However, the data available to us was insufficient for us to draw conclusions on the effectiveness of different types of skin grafts or tissue replacement therapies, and evidence of long‐term effectiveness is lacking. Furthermore, the potential benefits of skin grafts and tissue replacements should be weighed against the high costs of these products. Finally, it is important to note that skin grafts and tissue replacements cannot be seen as a treatment on their own, but should always be part of the multidisciplinary approach to this complex, chronic disease. </p> </section> <h3 class="title" id="CD011255-sec-0099">Implications for research</h3> <section id="CD011255-sec-0099"> <p>Most of the evidence which is currently available is derived from small studies with short follow‐up periods. Further research is needed to assess long‐term effectiveness of skin grafts and tissue replacement products. Recurrence rates, adverse events and amputation rates are essential outcomes and should be implemented in future studies. We also recommend quality of life and cost‐effectiveness as important outcomes. Cost‐effectiveness could also be assessed in observational studies when evidence for the effectiveness is more solid. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011255-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011255-sec-0029"></div> <div class="table" id="CD011255-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Skin grafts and tissue replacements compared to placebo or standard care for treating foot ulcers in people with diabetes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Skin grafts and tissue replacements compared to placebo or standard care for treating foot ulcers in people with diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> People with diabetes who have foot ulcers<br/> <b>Intervention:</b> Skin grafts and tissue replacements<br/> <b>Comparison:</b> Standard care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Standard care</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Skin grafts and tissue replacement products</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of complete closure of the ulcer (healing rate)</b> </p> <p>Follow‐up: 6 to 16 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>273 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>423 per 1000</b> (354 to 504) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.55</b> (1.30 to 1.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1472<br/> (13 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded to low quality of evidence due to lack of blinding, industry involvement and possible publication bias. Furthermore we found wide confidence intervals for a number of comparisons (imprecision). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to complete closure of the ulcer</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to compete healing of the ulcer was reported very heterogeneously. The majority of studies did not used survival analysis and reported hazard ratios, so meta‐analysis was not possible for this outcome and grading the quality of the evidence was not applicable </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total incidence of lower limb amputations</p> <p>Follow‐up: 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>109 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>47 per 1000</b> (25 to 89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.43</b> (0.23 – 0.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>522<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded by three levels because only two studies reported on this outcome (imprecision) and possible publication bias is present. Furthermore, a longer follow‐up period is necessary to estimate the effect more precisely. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; RCT: randomised controlled trial; RR: risk ratio; N/A: not applicable </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011255-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011255-sec-0030"></div> <section id="CD011255-sec-0031"> <h3 class="title" id="CD011255-sec-0031">Description of the condition</h3> <p>Foot ulceration is a major problem in people with diabetes, and is often caused by a combination of factors such as neuropathy (nerve damage), foot deformity, external trauma or peripheral arterial disease (<a href="./references#CD011255-bbs2-0034" title="BoultonAJ . The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes/Metabolism Research and Reviews2008;24 Suppl 1:3‐6. ">Boulton 2008</a>; <a href="./references#CD011255-bbs2-0043" title="FalangaV . Wound healing and its impairment in the diabetic foot. Lancet2005;366(9498):1736‐43. ">Falanga 2005</a>; <a href="./references#CD011255-bbs2-0065" title="QuattriniC , JeziorskaM , BoultonAJ , MalikRA . Reduced vascular endothelial growth factor expression and intra‐epidermal nerve fiber loss in human diabetic neuropathy. Diabetes Care2008;31:140‐5. ">Quattrini 2008</a>; <a href="./references#CD011255-bbs2-0076" title="SzaboC . Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction. British Journal of Pharmacology2009;156:713‐27. ">Szabo 2009</a>). A diabetic foot ulcer has been defined as a wound of full‐thickness (into the subcutaneous tissue, the innermost layer of the skin) below the ankle, or as a lesion of the foot penetrating through the dermis (the inner layer of the skin), in people with type 1 or type 2 diabetes (<a href="./references#CD011255-bbs2-0031" title="ApelqvistJ , LarssonJ . What is the most effective way to reduce incidence of amputation in the diabetic foot?. Diabetes/Metabolism Research and Reviews1999;16 Suppl 1:75‐83. ">Apelqvist 1999</a>; <a href="./references#CD011255-bbs2-0067" title="SchaperNC . Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes/Metabolism Research and Reviews2004;20 Suppl 1:S90‐5. ">Schaper 2004</a>). </p> <p>Worldwide, almost 350 million people have been diagnosed with diabetes mellitus, and this number is still increasing (<a href="./references#CD011255-bbs2-0036" title="DanaeiG , FinucaneMM , LuY , SinghGM , CowanMJ , PaciorekCJ , et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country‐years and 2·7 million participants. The Lancet2011;378(9785):31‐40. ">Danaei 2011</a>). The annual incidence of development of a foot ulcer in people with diabetes is 1% to 4%, and the lifetime risk is approximately 12% to 25% (<a href="./references#CD011255-bbs2-0029" title="AbbottCA , GarrowAP , CarringtonAL , MorrisJ , VanRossER , BoultonAJ . Foot ulcer risk is lower in South Asian and African‐Caribbean compared to European diabetic patients in the UK: the North‐West Diabetes Footcare Study. Diabetes Care2005;28(8):1869–75. ">Abbot 2005</a>; <a href="./references#CD011255-bbs2-0072" title="SinghN , ArmstrongDG , LipskyBA . Preventing foot ulcers in patients with diabetes. JAMA2005;293:217‐28. ">Singh 2005</a>). These ulcers are a leading cause of hospitalisation and major amputations (above the ankle joint) (<a href="./references#CD011255-bbs2-0059" title="LevinM . Prevention and treatment of diabetic foot ulcers. Journal of Wound Ostomy and Continence Nursing1998;21:129‐46. ">Levin 1998</a>; <a href="./references#CD011255-bbs2-0064" title="PhamHT , RichJ , VevesA . Wound healing in diabetic foot ulceration. A review and commentary. Wounds2000;12(4):79‐82. ">Pham 2000</a>). About 85% of amputations are preceded by ulceration (<a href="./references#CD011255-bbs2-0034" title="BoultonAJ . The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes/Metabolism Research and Reviews2008;24 Suppl 1:3‐6. ">Boulton 2008</a>). After amputation there is a high risk of re‐amputation at a higher level on the same limb (<a href="./references#CD011255-bbs2-0052" title="IzumiY , SatterfieldK , LeeS , HarklessLB , LaveryLA . Mortality of first‐time amputees in diabetics: a 10‐year observation. Diabetes Research and Clinical Practice2009;83:126‐31. ">Izumi 2009</a>; <a href="./references#CD011255-bbs2-0073" title="SkoutasD , PapanasN , GeorgiadisGS , ZervasV , ManesC , MaltezosE , et al. Risk factors for ipsilateral reamputation in patients with diabetic foot lesions. The International Journal of Lower Extremity Wounds2009;8:69‐74. ">Skoutas 2009</a>). It is estimated that worldwide there is an amputation due to diabetes every 30 seconds (<a href="./references#CD011255-bbs2-0046" title="GameF . Choosing life or limb. Improving survival in the multi‐complex diabetic foot patient. Diabetes/Metabolism Research and Reviews2012;28 Suppl 1:97‐100. ">Game 2012</a>). </p> <p>Current treatment of foot ulcers in people with diabetes usually consists of pressure off‐loading (keeping weight off the area) (<a href="./references#CD011255-bbs2-0060" title="LewisJ , LippA . Pressure‐relieving interventions for treating diabetic foot ulcers. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD002302.pub2] ">Lewis 2013</a>), debridement (removal of dead tissue) (<a href="./references#CD011255-bbs2-0041" title="EdwardsJ , StapleyS . Debridement of diabetic foot ulcers. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD003556.pub2] ">Edwards 2010</a>), infection control, the use of wound dressings or topical agents (<a href="./references#CD011255-bbs2-0032" title="BerginS , WraightP . Silver based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD005082.pub2] ">Bergin 2006</a>; <a href="./references#CD011255-bbs2-0037" title="DumvilleJC , O'MearaS , DeshpandeS , SpeakK . Alginate dressings for healing diabetic foot ulcers. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009110.pub3] ">Dumville 2013a</a>; <a href="./references#CD011255-bbs2-0038" title="DumvilleJC , DeshpandeS , O'MearaS , SpeakK . Foam dressings for healing diabetic foot ulcers. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009111.pub3] ">Dumville 2013b</a>; <a href="./references#CD011255-bbs2-0039" title="DumvilleJC , O'MearaS , DeshpandeS , SpeakK . Hydrogel dressings for healing diabetic foot ulcers. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD009101.pub3] ">Dumville 2013c</a>; <a href="./references#CD011255-bbs2-0040" title="DumvilleJC , DeshpandeS , O'MearaS , SpeakK . Hydrocolloid dressings for healing diabetic foot ulcers. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD009099.pub3] ">Dumville 2013d</a>; <a href="./references#CD011255-bbs2-0055" title="JullAB , WalkerN , DeshpandeS . Honey as a topical treatment for wounds. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD005083.pub3] ">Jull 2013</a>), intensive regulation of blood glucose (<a href="./references#CD011255-bbs2-0044" title="FernandoME , SeneviratneRM , CunninghamM , LazzariniPA , SanglaKS , Mong TangY , et al. Intensive versus conventional glycaemic control for treating diabetic foot ulcers. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD010764] ">Fernando 2013</a>), and, in the case of ischaemia, vascular reconstruction (<a href="./references#CD011255-bbs2-0043" title="FalangaV . Wound healing and its impairment in the diabetic foot. Lancet2005;366(9498):1736‐43. ">Falanga 2005</a>). Additional treatments such as hyperbaric oxygen therapy (<a href="./references#CD011255-bbs2-0056" title="KrankeP , BennettMH , Martyn‐St JamesM , SchnabelA , DebusSE , WeibelS . Hyperbaric oxygen therapy for chronic wounds. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD004123.pub3] ">Kranke 2015</a>; <a href="./references#CD011255-bbs2-0075" title="StoekenbroekRM , SantemaTB , LegemateDA , UbbinkDT , van denBrinkA , KoelemayMJ . Hyperbaric oxygen for the treatment of diabetic foot ulcers: a systematic review. European Journal of Vascular and Endovascular Surgery2014;47(6):647‐55. ">Stoekenbroek 2014</a>) and granulocyte‐colony stimulating factor (<a href="./references#CD011255-bbs2-0035" title="CrucianiM , LipskyBA , MengoliC , deLallaF . Granulocyte‐colony stimulating factors as adjunctive therapy for diabetic foot infections. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD006810.pub3] ">Cruciani 2013</a>) may also be used. Despite these multidisciplinary treatments, complete healing is not accomplished in 24% to 60% of ulcers (<a href="./references#CD011255-bbs2-0051" title="HinchliffeRJ , AndrosG , ApelqvistJ , BakkerK , FriederichsS , LammerJ , et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diabetes/Metabolism Research and Reviews2012;28 Suppl 1:179‐217. ">Hinchliffe 2012</a>; <a href="./references#CD011255-bbs2-0061" title="MargolisDJ , KantorJ , BerlinJA . Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta‐analysis. Diabetes Care1999;22:692‐5. ">Margolis 1999</a>). </p> <p>Diabetic foot ulceration has a great impact on quality of life and poses a significant burden on the healthcare budget (<a href="./references#CD011255-bbs2-0063" title="Nabuurs‐FranssenMH , HuijbertsMS , Nieuwenhuijzen KrusemanAC , WillemsJ , SchaperNC . Health‐related quality of life of diabetic foot ulcer patients and their caregivers. Diabetologia2005;48(9):1906‐10. ">Nabuurs‐Franssen 2005</a>; <a href="./references#CD011255-bbs2-0078" title="ValensiP , GirodI , BaronF , Moreau‐DefargesT , GuillonP . Quality of life and clinical correlates in patients with diabetic foot ulcers. Diabetes &amp; Metabolism2005;31:263‐71. ">Valensi 2005</a>). The direct medical costs of each ulcer can frequently exceed USD 45,000 (<a href="./references#CD011255-bbs2-0053" title="JeffcoateWJ , HardingKG . Diabetic foot ulcers. The Lancet2003;261:1545‐51. ">Jeffcoate 2003</a>; <a href="./references#CD011255-bbs2-0054" title="JeffcoateWJ , vanHoutumWH . Amputation as a marker of the quality of foot care in diabetes. Diabetologia2004;47:2051‐8. ">Jeffcoate 2004</a>; <a href="./references#CD011255-bbs2-0074" title="StocklK , VanderplasA , TafesseE , ChangE . Costs of lower‐extremity ulcers among patients with diabetes. Diabetes Care2004;27:2129–34. ">Stockl 2004</a>). The overall long‐term costs attributable to diabetic foot ulceration were analysed over a period of three years (<a href="./references#CD011255-bbs2-0030" title="ApelqvistJ , Ragnarson‐TennvallG , LarssonJ , PerssonU . Long‐term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot &amp; Ankle International1995;16(7):388‐94. ">Apelqvist 1995</a>). This showed that the costs, including inpatient care, outpatient care, home care and social services, ranged from USD 16,100 in a person with a healed ulcer without critical ischaemia to USD 63,100 in people who underwent a major amputation. </p> </section> <section id="CD011255-sec-0032"> <h3 class="title" id="CD011255-sec-0032">Description of the intervention</h3> <p>Skin grafts and tissue replacement can be used to treat foot ulcers in people with diabetes by reconstructing the skin defect. Skin substitutes need to be placed on a prepared wound bed to ensure contact between the wound bed and the graft and they take on the functions of the missing skin layer. Before the skin substitute is applied ulcers are usually rinsed and debrided to remove hyperkeratinised (abnormally horny or thickened skin) or necrotic tissue. The method of clinical application of the graft/tissue replacement and the frequency of application depends on the specific product used. Some skin substitutes are designed for temporary wounds coverage and some as a permanent replacement. </p> <p>Different types of skin grafts and tissue replacements are currently available. These are generally divided into the following categories: autografts (taken from the patient), allografts (taken from one person, given to another) and xenografts (taken from animals), and bioengineered tissue or artificial skin. They are used in a number of ways. </p> <p> <ul id="CD011255-list-0001"> <li> <p><i>Autografts:</i> skin taken from the patient and placed directly in the bed of the target ulcer (e.g. split‐skin or full‐thickness skin from pinch or mesh grafts). </p> </li> <li> <p><i>Allografts and xenografts:</i> skin taken from other humans or animals with a similar skin structure, placed directly in the bed of the target ulcer. </p> </li> <li> <p><i>Bioengineered or artificial skin:</i> skin replacement products created in a laboratory from cultures of skin components and cells (e.g. fibroblasts or keratinocytes), and then placed in the bed of the target ulcer. </p> </li> </ul> </p> <p>Grafting and tissue replacement of allogeneic skin are associated with some risk of transmission of infections such as hepatitis or the human immunodeficiency virus (HIV). Even with screening for these diseases in donors, this risk is not eliminated entirely (<a href="./references#CD011255-bbs2-0042" title="FalangaV , MargolisD , AlvarezO , AulettaM , MaggiacomoF , AltmanM , et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Archives of Dermatology1998;134:293‐300. ">Falanga 1998</a>). </p> </section> <section id="CD011255-sec-0033"> <h3 class="title" id="CD011255-sec-0033">How the intervention might work</h3> <p>Despite the current variety of strategies available for the treatment of foot ulcers in people with diabetes, not all ulcers achieve complete healing. Additional treatments with skin grafts and tissue replacement products have been developed that aim to promote complete wound closure by reconstructing the skin defect. It is believed that tissue replacements promote complete closure of the ulcer through the addition of extracellular matrices that induce growth factors and cytokine expression, although the exact mechanism underlying the process remains unclear. </p> </section> <section id="CD011255-sec-0034"> <h3 class="title" id="CD011255-sec-0034">Why it is important to do this review</h3> <p>The treatment of foot ulcers in people with diabetes is complex and challenging. Foot ulceration continues to be the leading risk factor for major amputation and is a significant burden to the healthcare system. Delayed ulcer healing is an example of the impaired process of wound healing (inflammation, tissue formation and tissue remodelling) characteristic of people with diabetes. Skin grafts and tissue replacements could function as a temporary cover for ulcers and aid normal wound healing alongside usual care that includes, for example, mechanical pressure relief and, in the case of ischaemia, vascular reconstruction. </p> <p>There are some reviews on the use of skin replacement therapies for treating foot ulcers in people with diabetes (<a href="./references#CD011255-bbs2-0033" title="BlozikE , SchererM . Skin replacement therapies for diabetic foot ulcers: systematic review and meta‐analysis. Diabetes Care2008;41(4):693‐4. ">Blozik 2008</a>; <a href="./references#CD011255-bbs2-0057" title="LangerA , RogowskiW . Systematic review of economic evaluations of human cell‐derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Services Research2009;9:115. ">Langer 2009</a>). One review suggests that tissue‐engineered artifical skin products may be cost‐effective in selected patients with chronic wounds (<a href="./references#CD011255-bbs2-0057" title="LangerA , RogowskiW . Systematic review of economic evaluations of human cell‐derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Services Research2009;9:115. ">Langer 2009</a>), however no recent review has included a rigorous quality assessment. </p> <p>This systematic review will examine current evidence for skin grafts and tissue replacement for treating foot ulcers in people with diabetes to inform current practice about effectiveness, costs and safety. The review will help clinicians to make informed decisions about the use of grafting and tissue replacement alongside usual care. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011255-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011255-sec-0035"></div> <p>To determine the benefits and harms of skin grafting and tissue replacement for treating foot ulcers in people with diabetes. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011255-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011255-sec-0036"></div> <section id="CD011255-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011255-sec-0038"> <h4 class="title">Types of studies</h4> <p>Randomised clinical trials (RCTs), in any setting. We included cross‐over trials only if the outcomes at the point of cross‐over were given. </p> </section> <section id="CD011255-sec-0039"> <h4 class="title">Types of participants</h4> <p>People (18 years of age or older) with diabetes mellitus types 1 or 2, who have been diagnosed with an open foot ulcer of ischaemic, neuropathic or neuroischaemic aetiology. We excluded trials that also include wounds of different aetiologies, such as burns, if the data for the diabetic foot ulcer subgroups were not reported separately. </p> </section> <section id="CD011255-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Skin grafts or tissue replacements applied to foot ulcers in people with diabetes. We included studies if they compared different types of skin grafts or tissue replacements, or compared skin grafts or tissue replacements with standard care or placebo. </p> </section> <section id="CD011255-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD011255-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD011255-list-0002"> <li> <p>Incidence of complete closure of the foot ulcer (healing rate).</p> </li> <li> <p>Time to complete closure of the foot ulcer.</p> </li> <li> <p>Total incidence of lower limb amputations (major and minor amputations with a minimum of one toe removed, defined as amputation above or below the ankle joint, respectively). </p> </li> </ul> </p> </section> <section id="CD011255-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD011255-list-0003"> <li> <p>Recurrence rate of foot ulcers.</p> </li> <li> <p>Change in ulcer area.</p> </li> <li> <p>Incidence of infection.</p> </li> <li> <p>Quality of life (as measured by a valid scale such as EQ‐5D or SF‐36).</p> </li> <li> <p>Safety (treatment‐related adverse events).</p> </li> <li> <p>Costs of treatment.</p> </li> </ul> </p> </section> </section> </section> <section id="CD011255-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011255-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We searched the following electronic databases to identify reports of relevant clinical trials: </p> <p> <ul id="CD011255-list-0004"> <li> <p>The Cochrane Wounds Specialised Register (searched 09 April 2015);</p> </li> <li> <p>The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2015, Issue 3); </p> </li> <li> <p>Ovid MEDLINE (1946 to 09 April 2015);</p> </li> <li> <p>Ovid MEDLINE (In‐Process &amp; Other Non‐Indexed Citations) (searched 09 April 2015);</p> </li> <li> <p>Ovid EMBASE (1974 to 09 April 2015);</p> </li> <li> <p>EBSCO CINAHL (1982 to 09 April 2015).</p> </li> </ul> </p> <p>The search strategies we used can be found in <a href="./appendices#CD011255-sec-0103">Appendix 1</a>. We combined the Ovid MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximising version (2008 revision) (<a href="./references#CD011255-bbs2-0058" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Lefebvre 2011</a>). We combined the Ovid EMBASE search with the Ovid EMBASE filter developed by the UK Cochrane Centre (<a href="./references#CD011255-bbs2-0058" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Lefebvre 2011</a>). We combined the EBSCO CINAHL searches with the trial filters developed by the Scottish Intercollegiate Guidelines Network (<a href="./references#CD011255-bbs2-0071" title="Scottish Intercollegiate Guidelines Network (SIGN). Search filters. http://www.sign.ac.uk/methodology/filters.html#random(accessed April 2014). ">SIGN 2014</a>). We did not impose any restrictions with respect to language, date of publication or study setting. </p> <p>We searched the following clinical trials registries in an effort to identify published, unpublished and ongoing trials: </p> <p> <ul id="CD011255-list-0005"> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>); </p> </li> <li> <p>ISRCTN registry (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com</a>); </p> </li> <li> <p>Trials Central (<a href="http://www.trialscentral.org/" target="_blank">www.trialscentral.org</a>); </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry (ICTR) (<a href="http://apps.who.int/trialsearch/Default.aspx" target="_blank">http://apps.who.int/trialsearch/Default.aspx</a>); </p> </li> <li> <p>The European Union (EU) Clinical Trials Register (<a href="http://www.clinicaltrialsregister.eu" target="_blank">www.clinicaltrialsregister.eu</a>). </p> </li> </ul> </p> </section> <section id="CD011255-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We handsearched the bibliographies of all relevant articles for further relevant studies.</p> </section> </section> <section id="CD011255-sec-0047"> <h3 class="title" id="CD011255-sec-0047">Data collection and analysis</h3> <p>We summarised data using standard Cochrane Collaboration methodologies (<a href="./references#CD011255-bbs2-0049" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). </p> <section id="CD011255-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Independently, two review authors (TS and DU) assessed titles and abstracts of the studies identified by the search strategy. We retrieved the full‐text of all potentially relevant abstracts and citations. Independently, these two review authors checked all full‐text papers for eligibility. Disagreements were resolved by discussion between the review authors, with the third review author (PP) acting as an arbitrator, if necessary. The selection process was recorded in sufficient detail to complete a PRISMA flow diagram (<a href="./references#CD011255-bbs2-0062" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , The PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: The PRISMA Statement. BMJ2009;339:2535. ">Moher 2009</a>), as shown in <a href="#CD011255-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD011255-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram of the number of records identified, included and excluded, and the reasons for exclusion" data-id="CD011255-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram of the number of records identified, included and excluded, and the reasons for exclusion </p> </div> </div> </div> </section> <section id="CD011255-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Details of eligible studies were extracted independently and summarised by two review authors using a standardised data extraction sheet. Discrepancies between review authors were resolved by discussion to achieve a final consensus, with the third author acting as an arbitrator, if necessary. Where data were missing from reports, we attempted to obtain the missing information by contacting the study author. One review author (TS) entered the data into Review Manager 5 (<a href="./references#CD011255-bbs2-0066" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), and two other authors (DU and PP) checked the entered data. </p> <p>We extracted the following data.</p> <p> <ul id="CD011255-list-0006"> <li> <p>Country of origin.</p> </li> <li> <p>Patient inclusion and exclusion criteria.</p> </li> <li> <p>Type of ulcer.</p> </li> <li> <p>Study setting.</p> </li> <li> <p>A priori sample size calculation.</p> </li> <li> <p>Unit of allocation and number of participants randomised to each intervention.</p> </li> <li> <p>Baseline participant data.</p> </li> <li> <p>Description of intervention and comparison.</p> </li> <li> <p>Details of any cointerventions.</p> </li> <li> <p>Types of primary and secondary outcome measures (with definitions).</p> </li> <li> <p>Primary and secondary outcome data.</p> </li> <li> <p>Duration of follow‐up.</p> </li> <li> <p>Number of withdrawals and reasons for withdrawal (by group).</p> </li> <li> <p>Adverse events (including amputations).</p> </li> <li> <p>Source of funding of the trial.</p> </li> </ul> </p> </section> <section id="CD011255-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Independently, two review authors assessed the risk of bias for each included study using the Cochrane tool for assessing risk of bias (<a href="./references#CD011255-bbs2-0050" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011b</a>). This tool addresses six specific domains, namely: sequence generation, allocation concealment, blinding, incomplete outcome data, selective reporting and other issues (e.g. extreme baseline imbalance or bias related to the specific study design). See <a href="./appendices#CD011255-sec-0104">Appendix 2</a> for the criteria on which we based our judgement. </p> <p>The authors assessed blinding and completeness of outcome data separately for each outcome. We completed a 'Risk of bias' table for each eligible study. We discussed any disagreement amongst all review authors to achieve a consensus. We presented the assessment of risk of bias using a 'Risk of bias' summary figure, which presents all of the judgements in a cross‐tabulation of study by entry (<a href="#CD011255-fig-0002">Figure 2</a>). This display of internal validity indicates the weight the reader may give the results of each study. Also see <a href="#CD011255-fig-0003">Figure 3</a> for a 'Risk of bias' graph. </p> <div class="figure" id="CD011255-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011255-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD011255-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011255-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> </section> <section id="CD011255-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>We calculated risk ratios (RRs) with 95% confidence intervals (CIs) for dichotomous outcomes, such as incidence of complete closure of the ulcer and incidence of amputation. For continuous outcomes, such as quality of life and cost, we would have calculated the difference in means (mean difference; MD) with 95% CIs as recommended by <a href="./references#CD011255-bbs2-0049" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>. For time to complete wound healing we planned to extract hazard ratios (HRs) with 95% CIs. </p> </section> <section id="CD011255-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>We dealt with unit of analysis issues according to guidance provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011255-bbs2-0049" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). We reported whether studies measured outcomes per person or per ulcer, and whether multiple ulcers on the same person were studied. Since the healing of multiple ulcers on an individual person cannot be considered to be independent events, we reported outcomes per person whenever possible. </p> </section> <section id="CD011255-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the study authors when data were incomplete or missing. Where trials reported outcomes only for participants who completed the follow‐up period, we treated the participants who were not included in the analysis as if their wound did not heal (e.g. withdrawals, participants lost‐to follow up or otherwise excluded from analysis). </p> <p>We evaluated whether an intention‐to‐treat (ITT) analysis was performed or could have been performed. An ITT analysis includes all participants randomised into a trial irrespective of what happened subsequently (<a href="./references#CD011255-bbs2-0049" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). </p> </section> <section id="CD011255-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>We evaluated clinical and methodological heterogeneity by comparing population, methods, interventions, and outcomes of studies. </p> <p>We assessed statistical heterogeneity by visual inspection of the forest plots (overlap of CIs) and by using the Chi² test and the I² statistic. If the P value of the Chi² test was greater than 0.1, no significant statistical heterogeneity was present. The I² statistic was interpreted as suggested by Higgins: 0% to 40% might not be important, 30% to 60% may represent moderate heterogeneity, 50% to 90% may represent substantial heterogeneity and 75% to 100% may represent considerable heterogeneity (<a href="./references#CD011255-bbs2-0048" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). </p> </section> <section id="CD011255-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>We used a funnel plot of primary outcomes to illustrate variability between trials visually and to assess whether the review was subject to publication bias. </p> </section> <section id="CD011255-sec-0056"> <h4 class="title">Data synthesis</h4> <p>Details of the studies that were eligible for inclusion in this review were presented narratively or, whenever appropriate, by using meta‐analysis. If trials were similar in terms of population, methods, interventions and outcomes, we considered pooling them using a fixed‐effects model to summarise their results. If the I² was less than 50%, we also presented the results of a random effects model and discussed which measure we believed to be the most appropriate. If I² was substantial (over 75%) we did not pool these studies. We presented risk ratios (RRs) with 95% confidence intervals (CIs) for dichotomous outcomes. If meta‐analysis had been possible for continuous outcomes, we would have calculated a pooled difference in means (mean difference; MD) with 95% CIs as recommended by <a href="./references#CD011255-bbs2-0049" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>. For time to complete wound healing we planned to plot hazard ratios (HRs) with 95% CIs using the generic inverse variance method in RevMan 5.3. </p> <section id="CD011255-sec-0057"> <h5 class="title">'Summary of findings' tables</h5> <p>We presented the main results of this review in 'Summary of findings' tables. These tables present key information concerning the quality of the evidence, the magnitude of the effects of the interventions examined, and the sum of the available data for the main outcomes (<a href="./references#CD011255-bbs2-0069" title="Schunemann 2011a SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , Guyatt GH. Chapter 11: Presentingresults , 'Summary of findings' tables. In: HigginsJPT . Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available fromwww.cochrane‐handbook.org . ">Schunemann 2011a</a>). The 'Summary of findings' tables also include an overall grading of the evidence related to each of the main outcomes using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach. The GRADE approach defines the quality of a body of evidence as the extent to which one can be confident that an estimate of effect or association is close to the true quantity of specific interest. The quality of a body of evidence involves consideration of within‐trial risk of bias (methodological quality), directness of evidence, heterogeneity, precision of effect estimates and risk of publication bias (<a href="./references#CD011255-bbs2-0070" title="SchünemannHJ , OxmanAD , HigginsJPT , DeeksJJ , GlasziouP , Guyatt GH. Chapter 12: Interpretingresults , drawing conclusions. In: HigginsJPT . Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available fromwww.cochrane‐handbook.org . ">Schunemann 2011b</a>). </p> </section> </section> <section id="CD011255-sec-0058"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We conducted subgroup analyses to examine the treatment effects of the different types of skin grafts or skin replacements. When subgroup analyses were not possible due to a lack of data, we reported the results narratively, according to the types of skin graft or replacement. </p> </section> <section id="CD011255-sec-0059"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted a sensitivity analysis to assess the impact of excluding trials assessed as being at high, or unclear, risk of bias. We excluded trials from this sensitivity analysis if they were at high risk or unclear risk of bias in at least two of the following three domains, namely: generation of the allocation sequence, concealment of allocation and blinding of outcome assessor. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011255-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011255-sec-0060"></div> <section id="CD011255-sec-0061"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD011255-sec-0142" title="">Characteristics of included studies</a>; <a href="./references#CD011255-sec-0143" title="">Characteristics of excluded studies</a>. </p> <section id="CD011255-sec-0062"> <h4 class="title">Results of the search</h4> <p>The initial search resulted in 283 potentially relevant records. After the first screening we selected 22 full‐text articles for a more detailed assessment. Seventeen studies were eligible for inclusion in this review (<a href="#CD011255-fig-0001">Figure 1</a>). We identified five ongoing studies (<a href="./references#CD011255-bbs2-0024" title="NCT01693133 . Trial of Dehydrated Human Amnion/Chorion Membrane (dHACM) In the Management of Diabetic Foot Ulcers. https://www.clinicaltrials.gov/ct2/show/NCT01693133 (accessed 14 August 2015). ">NCT01693133</a>; <a href="./references#CD011255-bbs2-0025" title="NCT02070835 . Study of ReCell® Treating for Diabetic Foot Ulcers. https://clinicaltrials.gov/ct2/show/NCT02070835 (accessed 14 August 2015). ">NCT02070835</a>; <a href="./references#CD011255-bbs2-0026" title="NCT02120755 . A Randomized Comparison of AmnioClear™ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds. https://clinicaltrials.gov/ct2/show/NCT02120755 (accessed 14 August 2015). ">NCT02120755</a>; <a href="./references#CD011255-bbs2-0027" title="NCT02331147 . Allogenic Dermis Versus Standard Care in the Management of Diabetic Foot Ulcers. https://clinicaltrials.gov/ct2/show/NCT02331147 (accessed 14 August 2015). ">NCT02331147</a>; <a href="./references#CD011255-bbs2-0028" title="NCT02399826 . Study of Amniotic Membrane Graft in the Management of Diabetic Foot Ulcers. https://clinicaltrials.gov/ct2/show/NCT02399826 (accessed 14 August 2015). ">NCT02399826</a>) and added these to <a href="./references#CD011255-sec-0144" title="">Characteristics of ongoing studies</a> for future assessment (checked ISRCTN register 14 August 2015). </p> </section> <section id="CD011255-sec-0063"> <h4 class="title">Included studies</h4> <p>We included seventeen RCTs with a total of 1655 randomised participants. Study size ranged from 23 to 314 included patients. Thirteen studies compared a skin graft or tissue replacement with standard care (<a href="./references#CD011255-bbs2-0001" title="BrigidoSA . The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot study. International Wound Journal2006;3(3):181‐7. ">Brigido 2006</a>; <a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a>; <a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>; <a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>; <a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0011" title="ReyzelmanA , CrewsRT , MooreJC , MooreL , MukkerJS , OffuttS , et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal2009;6(3):196‐208. ">Reyzelman 2009</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>; <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>; <a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a>; <a href="./references#CD011255-bbs2-0017" title="ZelenCM , SerenaTE , DenoziereG , FetterolfDE . A prospective, randomised comparative parallel study amniotic membrane wound graft in the management of diabetic foot ulcers. International Wound Journal2013;10(5):502‐7. ">Zelen 2013</a>). Four studies investigated the effectiveness of two different types of grafts (<a href="./references#CD011255-bbs2-0003" title="DiDomenicoL , EmchKJ , LandsmanAR , LandsmanA . A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute. Wounds2011;23(7):184‐9. ">DiDomenico 2011</a>; <a href="./references#CD011255-bbs2-0006" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;23(3):149‐56. LandsmanA , RoukisTS , DeFronzoDJ , AgnewP , PetrantoRD , SuprenantM . Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers. Wounds2008;20(5):111‐6. ">Landsman 2008</a>; <a href="./references#CD011255-bbs2-0010" title="PuttirutvongP . Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand2004;87(1):66‐72. ">Puttirutvong 2004</a>; <a href="./references#CD011255-bbs2-0012" title="SandersL , LandsmanAD , LandsmanA , KellerN , CookJ , HopsonM . A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft. Ostomy Wound Management2014;60(8):26‐38. ">Sanders 2014</a>). </p> <section id="CD011255-sec-0064"> <h5 class="title">Study setting</h5> <p>Four studies were single‐centred (<a href="./references#CD011255-bbs2-0001" title="BrigidoSA . The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot study. International Wound Journal2006;3(3):181‐7. ">Brigido 2006</a>; <a href="./references#CD011255-bbs2-0003" title="DiDomenicoL , EmchKJ , LandsmanAR , LandsmanA . A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute. Wounds2011;23(7):184‐9. ">DiDomenico 2011</a>; <a href="./references#CD011255-bbs2-0010" title="PuttirutvongP . Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand2004;87(1):66‐72. ">Puttirutvong 2004</a>; <a href="./references#CD011255-bbs2-0017" title="ZelenCM , SerenaTE , DenoziereG , FetterolfDE . A prospective, randomised comparative parallel study amniotic membrane wound graft in the management of diabetic foot ulcers. International Wound Journal2013;10(5):502‐7. ">Zelen 2013</a>) and thirteen were multi‐centred (<a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a>; <a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0006" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;23(3):149‐56. LandsmanA , RoukisTS , DeFronzoDJ , AgnewP , PetrantoRD , SuprenantM . Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers. Wounds2008;20(5):111‐6. ">Landsman 2008</a>; <a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>; <a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>; <a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0011" title="ReyzelmanA , CrewsRT , MooreJC , MooreL , MukkerJS , OffuttS , et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal2009;6(3):196‐208. ">Reyzelman 2009</a>; <a href="./references#CD011255-bbs2-0012" title="SandersL , LandsmanAD , LandsmanA , KellerN , CookJ , HopsonM . A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft. Ostomy Wound Management2014;60(8):26‐38. ">Sanders 2014</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>; <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>; <a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a>). Most (11/17) studies were undertaken in the United States. One study was multinational, taking place in the European Union and Australia (<a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>), one was conducted in Thailand (<a href="./references#CD011255-bbs2-0010" title="PuttirutvongP . Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand2004;87(1):66‐72. ">Puttirutvong 2004</a>), two in Korea (<a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>; <a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a>) and two in Italy (<a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>). None of the studies provided a detailed description of the study setting, but it appears that in general, studies were conducted in an outpatient hospital setting. </p> </section> <section id="CD011255-sec-0065"> <h5 class="title">Inclusion and exclusion criteria</h5> <p>Inclusion and exclusion criteria were clearly listed in most trials (15/17). Two publications lacked a complete description of the selected patients (<a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0010" title="PuttirutvongP . Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand2004;87(1):66‐72. ">Puttirutvong 2004</a>). </p> <p>The majority of studies (15/17) excluded patients with an infection of the target ulcer. One study allowed the inclusion of ulcers with limited infection, as only patients with cellulitis or osteomyelitis were excluded (<a href="./references#CD011255-bbs2-0006" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;23(3):149‐56. LandsmanA , RoukisTS , DeFronzoDJ , AgnewP , PetrantoRD , SuprenantM . Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers. Wounds2008;20(5):111‐6. ">Landsman 2008</a>). In another study, only ulcers with the absence of deep abscesses, gangrene or necrotising fasciitis were included (<a href="./references#CD011255-bbs2-0010" title="PuttirutvongP . Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand2004;87(1):66‐72. ">Puttirutvong 2004</a>). </p> <p>Adequate arterial perfusion of the foot was required for inclusion in all fifteen trials that described their inclusion and exclusion criteria. </p> <p>More than half of the studies (10/17) included chronic, or hard‐to‐heal ulcers that were present for at least four to six weeks (<a href="./references#CD011255-bbs2-0001" title="BrigidoSA . The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot study. International Wound Journal2006;3(3):181‐7. ">Brigido 2006</a>; <a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a>; <a href="./references#CD011255-bbs2-0003" title="DiDomenicoL , EmchKJ , LandsmanAR , LandsmanA . A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute. Wounds2011;23(7):184‐9. ">DiDomenico 2011</a>; <a href="./references#CD011255-bbs2-0006" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;23(3):149‐56. LandsmanA , RoukisTS , DeFronzoDJ , AgnewP , PetrantoRD , SuprenantM . Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers. Wounds2008;20(5):111‐6. ">Landsman 2008</a>; <a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>; <a href="./references#CD011255-bbs2-0012" title="SandersL , LandsmanAD , LandsmanA , KellerN , CookJ , HopsonM . A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft. Ostomy Wound Management2014;60(8):26‐38. ">Sanders 2014</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>; <a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a>; <a href="./references#CD011255-bbs2-0017" title="ZelenCM , SerenaTE , DenoziereG , FetterolfDE . A prospective, randomised comparative parallel study amniotic membrane wound graft in the management of diabetic foot ulcers. International Wound Journal2013;10(5):502‐7. ">Zelen 2013</a>). Four studies included ulcers that were present for at least two weeks (<a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>; <a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>). Three studies did not specify the minimum period of ulcer duration in their inclusion criteria (<a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0010" title="PuttirutvongP . Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand2004;87(1):66‐72. ">Puttirutvong 2004</a>; <a href="./references#CD011255-bbs2-0011" title="ReyzelmanA , CrewsRT , MooreJC , MooreL , MukkerJS , OffuttS , et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal2009;6(3):196‐208. ">Reyzelman 2009</a>). </p> </section> <section id="CD011255-sec-0066"> <h5 class="title">Follow‐up period</h5> <p>The follow‐up period ranged from six weeks (<a href="./references#CD011255-bbs2-0017" title="ZelenCM , SerenaTE , DenoziereG , FetterolfDE . A prospective, randomised comparative parallel study amniotic membrane wound graft in the management of diabetic foot ulcers. International Wound Journal2013;10(5):502‐7. ">Zelen 2013</a>) to 14 months (<a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>), but most trials (11/17) reported a follow‐up period of 12 weeks (<a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0006" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;23(3):149‐56. LandsmanA , RoukisTS , DeFronzoDJ , AgnewP , PetrantoRD , SuprenantM . Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers. Wounds2008;20(5):111‐6. ">Landsman 2008</a>, <a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>; <a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>; <a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0011" title="ReyzelmanA , CrewsRT , MooreJC , MooreL , MukkerJS , OffuttS , et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal2009;6(3):196‐208. ">Reyzelman 2009</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>; <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>; <a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a>). </p> </section> <section id="CD011255-sec-0067"> <h5 class="title">Sample size</h5> <p>An a priori sample size calculation was described in only three studies (<a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a>, <a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>, <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>). In only one of these trials (<a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a>) the chosen effect size was clearly described. In this trial they calculated a sample size of 78 participants to detect a difference in healing rate after 30 days with 70% of ulcers healing in the intervention group and 30% of ulcers healing in the control group. </p> <p>Most trials included less than 100 participants, whereas four trials included more than 100 participants (<a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>, <a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>, <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>, <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>). The largest included trial in this review had 314 participants (<a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>), while the smallest had only 23 participants (<a href="./references#CD011255-bbs2-0012" title="SandersL , LandsmanAD , LandsmanA , KellerN , CookJ , HopsonM . A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft. Ostomy Wound Management2014;60(8):26‐38. ">Sanders 2014</a>). </p> </section> </section> <section id="CD011255-sec-0068"> <h4 class="title">Excluded studies</h4> <p>We excluded five studies from this review. We excluded three single‐centre studies since the results were incorporated in multicentre studies already included in this review (<a href="./references#CD011255-bbs2-0018" title="HanftJR , SuprenantMS . Healing of chronic foot ulcer in diabetic patients treated with a human fibroblast‐derived dermis. The Journal of Foot &amp; Ankle Surgery2002;41(5):291‐9. ">Hanft 2002</a>; <a href="./references#CD011255-bbs2-0021" title="PhamHT , RosenblumBI , LyonsTE , GiueiniJM , CharzanJS , HabershawGM , et al. Evaluation of a human skin equivalent for the treatment of diabetic foot ulcers in a prospective, randomized, clinical trial. Wounds1999;11(4):1044‐6. ">Pham 1999</a>; <a href="./references#CD011255-bbs2-0022" title="SamsHH , ChenJ , KingLE . Graftskin treatment of difficult to heal diabetic foot ulcers: one center's experience. Dermatologic Surgery2002;28:698‐703. ">Sams 2002</a>). Also the use of a recombinant human platelet‐derived growth factor in the control group (<a href="./references#CD011255-bbs2-0020" title="NiezgodaJA , VanGilsCC , FrykbergRG , HoddeJP . Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Advances in Skin &amp; Wound Care2005;18(5 Pt 1):258‐66. ">Niezgoda 2005</a>), and the lack of outcome data before treatment switch in a cross‐over study led to exclusion (<a href="./references#CD011255-bbs2-0019" title="MoustafaM , BullockAJ , CreaghFM , HellerS , JeffcoateW , GameF , et al. Randomized, controlled, single‐blind study on use of autologous keratinocytes on a transfer dressing to treat nonhealing diabetic ulcers. Regenerative medicine2007;2(6):887‐902. ">Moustafa 2007</a>). </p> </section> </section> <section id="CD011255-sec-0069"> <h3 class="title">Risk of bias in included studies</h3> <p>Further details of each study are documented in the <a href="./references#CD011255-sec-0142" title="">Characteristics of included studies</a> and the ‘Risk of bias’ summary figures (<a href="#CD011255-fig-0002">Figure 2</a> and <a href="#CD011255-fig-0003">Figure 3</a>). </p> <section id="CD011255-sec-0070"> <h4 class="title">Allocation</h4> <section id="CD011255-sec-0071"> <h5 class="title">Randomisation sequence generation</h5> <p>Ten studies reported a random component in the sequence generation process, such as a computer‐generated random number table or a randomisation schedule (<a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a>; <a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>; <a href="./references#CD011255-bbs2-0012" title="SandersL , LandsmanAD , LandsmanA , KellerN , CookJ , HopsonM . A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft. Ostomy Wound Management2014;60(8):26‐38. ">Sanders 2014</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>; <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>; <a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a>; <a href="./references#CD011255-bbs2-0017" title="ZelenCM , SerenaTE , DenoziereG , FetterolfDE . A prospective, randomised comparative parallel study amniotic membrane wound graft in the management of diabetic foot ulcers. International Wound Journal2013;10(5):502‐7. ">Zelen 2013</a>). </p> <p>In one study, an error in the randomisation scheme led to an uneven patient distribution. We considered the risk of bias to be high for this study (<a href="./references#CD011255-bbs2-0003" title="DiDomenicoL , EmchKJ , LandsmanAR , LandsmanA . A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute. Wounds2011;23(7):184‐9. ">DiDomenico 2011</a>). The remaining six studies were described as being randomised, but provided insufficient information about the method of random sequence generation. We therefore classified these studies at an unclear risk of bias for this domain (<a href="./references#CD011255-bbs2-0001" title="BrigidoSA . The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot study. International Wound Journal2006;3(3):181‐7. ">Brigido 2006</a>; <a href="./references#CD011255-bbs2-0006" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;23(3):149‐56. LandsmanA , RoukisTS , DeFronzoDJ , AgnewP , PetrantoRD , SuprenantM . Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers. Wounds2008;20(5):111‐6. ">Landsman 2008</a>; <a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>; <a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0010" title="PuttirutvongP . Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand2004;87(1):66‐72. ">Puttirutvong 2004</a>; <a href="./references#CD011255-bbs2-0011" title="ReyzelmanA , CrewsRT , MooreJC , MooreL , MukkerJS , OffuttS , et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal2009;6(3):196‐208. ">Reyzelman 2009</a>). </p> </section> <section id="CD011255-sec-0072"> <h5 class="title">Allocation concealment</h5> <p>In eight studies the treatment allocation was adequately concealed. Five of these studies reported the use of sealed envelopes (<a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0012" title="SandersL , LandsmanAD , LandsmanA , KellerN , CookJ , HopsonM . A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft. Ostomy Wound Management2014;60(8):26‐38. ">Sanders 2014</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>). One study reported a central independent allocation method (<a href="./references#CD011255-bbs2-0006" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;23(3):149‐56. LandsmanA , RoukisTS , DeFronzoDJ , AgnewP , PetrantoRD , SuprenantM . Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers. Wounds2008;20(5):111‐6. ">Landsman 2008</a>), and another study concealed the allocation by using a computer‐generated randomisation code (<a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>). <a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a> reported that the "randomisation schedule was held by the sponsor." The remaining nine trials did not describe the method of allocation concealment. We classified these studies at an unclear risk of bias for this domain. </p> </section> </section> <section id="CD011255-sec-0073"> <h4 class="title">Blinding</h4> <section id="CD011255-sec-0074"> <h5 class="title">Blinding of participants and personnel</h5> <p>None of the included studies described blinding of personnel. Participants were blinded to the treatment allocation in three of the included studies (<a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>; <a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>) and we therefore classified them at a low risk of bias for this domain. We considered nine studies to be at a high risk of bias for this domain because they were described as open‐label or single‐blinded studies (<a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a>; <a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0006" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;23(3):149‐56. LandsmanA , RoukisTS , DeFronzoDJ , AgnewP , PetrantoRD , SuprenantM . Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers. Wounds2008;20(5):111‐6. ">Landsman 2008</a>; <a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>; <a href="./references#CD011255-bbs2-0012" title="SandersL , LandsmanAD , LandsmanA , KellerN , CookJ , HopsonM . A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft. Ostomy Wound Management2014;60(8):26‐38. ">Sanders 2014</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>; <a href="./references#CD011255-bbs2-0017" title="ZelenCM , SerenaTE , DenoziereG , FetterolfDE . A prospective, randomised comparative parallel study amniotic membrane wound graft in the management of diabetic foot ulcers. International Wound Journal2013;10(5):502‐7. ">Zelen 2013</a>). The remaining five studies provided no information regarding blinding of participants and personnel (<a href="./references#CD011255-bbs2-0001" title="BrigidoSA . The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot study. International Wound Journal2006;3(3):181‐7. ">Brigido 2006</a>; <a href="./references#CD011255-bbs2-0003" title="DiDomenicoL , EmchKJ , LandsmanAR , LandsmanA . A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute. Wounds2011;23(7):184‐9. ">DiDomenico 2011</a>; <a href="./references#CD011255-bbs2-0010" title="PuttirutvongP . Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand2004;87(1):66‐72. ">Puttirutvong 2004</a>; <a href="./references#CD011255-bbs2-0011" title="ReyzelmanA , CrewsRT , MooreJC , MooreL , MukkerJS , OffuttS , et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal2009;6(3):196‐208. ">Reyzelman 2009</a>; <a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a>) and we classified them as having an unclear risk of bias for this domain. </p> </section> <section id="CD011255-sec-0075"> <h5 class="title">Blinding of outcome assessment</h5> <p>Blinded assessment of the outcome was described in only one study <a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>). Nine studies specifically stated the lack of outcome assessment and we classified them at a high risk of bias for this domain (<a href="./references#CD011255-bbs2-0006" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;23(3):149‐56. LandsmanA , RoukisTS , DeFronzoDJ , AgnewP , PetrantoRD , SuprenantM . Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers. Wounds2008;20(5):111‐6. ">Landsman 2008</a>; <a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>; <a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0011" title="ReyzelmanA , CrewsRT , MooreJC , MooreL , MukkerJS , OffuttS , et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal2009;6(3):196‐208. ">Reyzelman 2009</a>; <a href="./references#CD011255-bbs2-0012" title="SandersL , LandsmanAD , LandsmanA , KellerN , CookJ , HopsonM . A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft. Ostomy Wound Management2014;60(8):26‐38. ">Sanders 2014</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>; <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>; <a href="./references#CD011255-bbs2-0017" title="ZelenCM , SerenaTE , DenoziereG , FetterolfDE . A prospective, randomised comparative parallel study amniotic membrane wound graft in the management of diabetic foot ulcers. International Wound Journal2013;10(5):502‐7. ">Zelen 2013</a>). The remaining seven studies provided no information regarding blinding of outcome assessment (<a href="./references#CD011255-bbs2-0001" title="BrigidoSA . The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot study. International Wound Journal2006;3(3):181‐7. ">Brigido 2006</a>; <a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a>; <a href="./references#CD011255-bbs2-0003" title="DiDomenicoL , EmchKJ , LandsmanAR , LandsmanA . A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute. Wounds2011;23(7):184‐9. ">DiDomenico 2011</a>; <a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0010" title="PuttirutvongP . Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand2004;87(1):66‐72. ">Puttirutvong 2004</a>; <a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a>) and we classified them as having an unclear risk of bias for this domain. </p> </section> </section> <section id="CD011255-sec-0076"> <h4 class="title">Incomplete outcome data</h4> <p>We classified 9 studies at low risk of bias for incomplete outcome data because the numbers and reasons for withdrawals were adequately described (<a href="./references#CD011255-bbs2-0001" title="BrigidoSA . The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot study. International Wound Journal2006;3(3):181‐7. ">Brigido 2006</a>; <a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a>; <a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>; <a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>; <a href="./references#CD011255-bbs2-0011" title="ReyzelmanA , CrewsRT , MooreJC , MooreL , MukkerJS , OffuttS , et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal2009;6(3):196‐208. ">Reyzelman 2009</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>; <a href="./references#CD011255-bbs2-0017" title="ZelenCM , SerenaTE , DenoziereG , FetterolfDE . A prospective, randomised comparative parallel study amniotic membrane wound graft in the management of diabetic foot ulcers. International Wound Journal2013;10(5):502‐7. ">Zelen 2013</a>). Four trials reported dropouts but failed to include all patients in the ITT analysis (<a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>; <a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a>). We judged these four studies to be at high risk of bias for this domain. The remaining four trials did not provide a statement regarding missing data and we classified them as having an unclear risk of bias for this domain (<a href="./references#CD011255-bbs2-0003" title="DiDomenicoL , EmchKJ , LandsmanAR , LandsmanA . A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute. Wounds2011;23(7):184‐9. ">DiDomenico 2011</a>; <a href="./references#CD011255-bbs2-0006" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;23(3):149‐56. LandsmanA , RoukisTS , DeFronzoDJ , AgnewP , PetrantoRD , SuprenantM . Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers. Wounds2008;20(5):111‐6. ">Landsman 2008</a>; <a href="./references#CD011255-bbs2-0010" title="PuttirutvongP . Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand2004;87(1):66‐72. ">Puttirutvong 2004</a>; <a href="./references#CD011255-bbs2-0012" title="SandersL , LandsmanAD , LandsmanA , KellerN , CookJ , HopsonM . A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft. Ostomy Wound Management2014;60(8):26‐38. ">Sanders 2014</a>). </p> </section> <section id="CD011255-sec-0077"> <h4 class="title">Selective reporting</h4> <p>The majority of studies (14/17) reported all clinically relevant outcomes without suggestion of selective reporting and we classified them at a low risk of bias for this domain (<a href="./references#CD011255-bbs2-0001" title="BrigidoSA . The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot study. International Wound Journal2006;3(3):181‐7. ">Brigido 2006</a>; <a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a>; <a href="./references#CD011255-bbs2-0003" title="DiDomenicoL , EmchKJ , LandsmanAR , LandsmanA . A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute. Wounds2011;23(7):184‐9. ">DiDomenico 2011</a>; <a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>; <a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>; <a href="./references#CD011255-bbs2-0010" title="PuttirutvongP . Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand2004;87(1):66‐72. ">Puttirutvong 2004</a>; <a href="./references#CD011255-bbs2-0011" title="ReyzelmanA , CrewsRT , MooreJC , MooreL , MukkerJS , OffuttS , et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal2009;6(3):196‐208. ">Reyzelman 2009</a>; <a href="./references#CD011255-bbs2-0012" title="SandersL , LandsmanAD , LandsmanA , KellerN , CookJ , HopsonM . A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft. Ostomy Wound Management2014;60(8):26‐38. ">Sanders 2014</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>; <a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a>; <a href="./references#CD011255-bbs2-0017" title="ZelenCM , SerenaTE , DenoziereG , FetterolfDE . A prospective, randomised comparative parallel study amniotic membrane wound graft in the management of diabetic foot ulcers. International Wound Journal2013;10(5):502‐7. ">Zelen 2013</a>). </p> <p>Primary outcomes were related to ulcer healing. Only <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a> reported on incidence of amputation as a separate outcome parameter. However, given the short follow‐up time, no statistically significant differences could be expected for this outcome. </p> <p>We classified three studies as having an unclear risk of bias for selective reporting. <a href="./references#CD011255-bbs2-0006" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;23(3):149‐56. LandsmanA , RoukisTS , DeFronzoDJ , AgnewP , PetrantoRD , SuprenantM . Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers. Wounds2008;20(5):111‐6. ">Landsman 2008</a> described that the wounds were measured at each time point. But data on the outcome ‘wound closure’ was only specified as incidence of ‘healed wounds’ and not as a measured change in wound size. In a second study, the primary outcome parameter was changed to the number of 'active implants', which resulted in less patients receiving the 'best treatment' (<a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>). In the third study, <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a> left out the exact numbers of patients in the ITT analysis. </p> <p>Some studies (7/17) failed to report outcomes based on ITT analyses or failed to include all randomised patients in the ITT analysis (<a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>; <a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0011" title="ReyzelmanA , CrewsRT , MooreJC , MooreL , MukkerJS , OffuttS , et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal2009;6(3):196‐208. ">Reyzelman 2009</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>; <a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a>). Because total number of participants was stated in each study, we were able to easily calculate the effects based on the ITT. We treated the participants who were not included in the analysis as if their wound did not heal (worst case scenario). </p> </section> <section id="CD011255-sec-0078"> <h4 class="title">Other potential sources of bias</h4> <p>We classified all studies as having an unclear risk of bias for this domain as no trial was completely free of components that could put it at risk of bias. For example, in three studies the baseline characteristics were not provided (<a href="./references#CD011255-bbs2-0001" title="BrigidoSA . The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot study. International Wound Journal2006;3(3):181‐7. ">Brigido 2006</a>; <a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>), while one study showed baseline differences (<a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>). </p> <p>Furthermore, nearly all studies (15/17) reported industry involvement; at least one of the authors was connected to a commercial organisation or the study was funded by a commercial organisation (<a href="./references#CD011255-bbs2-0001" title="BrigidoSA . The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot study. International Wound Journal2006;3(3):181‐7. ">Brigido 2006</a>; <a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a>; <a href="./references#CD011255-bbs2-0003" title="DiDomenicoL , EmchKJ , LandsmanAR , LandsmanA . A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute. Wounds2011;23(7):184‐9. ">DiDomenico 2011</a>; <a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>; <a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>; <a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0011" title="ReyzelmanA , CrewsRT , MooreJC , MooreL , MukkerJS , OffuttS , et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal2009;6(3):196‐208. ">Reyzelman 2009</a>; <a href="./references#CD011255-bbs2-0012" title="SandersL , LandsmanAD , LandsmanA , KellerN , CookJ , HopsonM . A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft. Ostomy Wound Management2014;60(8):26‐38. ">Sanders 2014</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>; <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>; <a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a>; <a href="./references#CD011255-bbs2-0017" title="ZelenCM , SerenaTE , DenoziereG , FetterolfDE . A prospective, randomised comparative parallel study amniotic membrane wound graft in the management of diabetic foot ulcers. International Wound Journal2013;10(5):502‐7. ">Zelen 2013</a>). </p> </section> </section> <section id="CD011255-sec-0079"> <h3 class="title" id="CD011255-sec-0079">Effects of interventions</h3> <p>See: <a href="./full#CD011255-tbl-0001"><b>Summary of findings for the main comparison</b> Skin grafts and tissue replacements compared to placebo or standard care for treating foot ulcers in people with diabetes</a> </p> <p>See: <a href="./full#CD011255-tbl-0001">summary of findings Table for the main comparison</a>. </p> <section id="CD011255-sec-0080"> <h4 class="title">Primary outcomes</h4> <section id="CD011255-sec-0081"> <h5 class="title">Incidence of complete closure of the ulcer (healing rate)</h5> <p>Thirteen studies compared a skin graft or tissue replacement with standard wound care and reported on incidence of complete closure of the ulcer. Compared products were Apligraf® or Graftskin® (<a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>), Dermagraft® (<a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>; <a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>), EpiFix® (<a href="./references#CD011255-bbs2-0017" title="ZelenCM , SerenaTE , DenoziereG , FetterolfDE . A prospective, randomised comparative parallel study amniotic membrane wound graft in the management of diabetic foot ulcers. International Wound Journal2013;10(5):502‐7. ">Zelen 2013</a>), Graftjacket® (<a href="./references#CD011255-bbs2-0001" title="BrigidoSA . The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot study. International Wound Journal2006;3(3):181‐7. ">Brigido 2006</a>; <a href="./references#CD011255-bbs2-0011" title="ReyzelmanA , CrewsRT , MooreJC , MooreL , MukkerJS , OffuttS , et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal2009;6(3):196‐208. ">Reyzelman 2009</a>), Hyalograft 3D® (<a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a>), Kaloderm® (<a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>) and OrCel® (<a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>). Pooling of the results was possible because all trials reported on incidence of complete closure at similar time points. Eleven trials reported on incidence of complete closure after 12 weeks (<a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>; <a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>; <a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0011" title="ReyzelmanA , CrewsRT , MooreJC , MooreL , MukkerJS , OffuttS , et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal2009;6(3):196‐208. ">Reyzelman 2009</a>; <a href="./references#CD011255-bbs2-0012" title="SandersL , LandsmanAD , LandsmanA , KellerN , CookJ , HopsonM . A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft. Ostomy Wound Management2014;60(8):26‐38. ">Sanders 2014</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>; <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>; <a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a>), one after 11 weeks (<a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a>), one after 16 weeks (<a href="./references#CD011255-bbs2-0001" title="BrigidoSA . The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot study. International Wound Journal2006;3(3):181‐7. ">Brigido 2006</a>) and one after six weeks (<a href="./references#CD011255-bbs2-0017" title="ZelenCM , SerenaTE , DenoziereG , FetterolfDE . A prospective, randomised comparative parallel study amniotic membrane wound graft in the management of diabetic foot ulcers. International Wound Journal2013;10(5):502‐7. ">Zelen 2013</a>). </p> <p>Pooling of these results by using a random‐effects model yielded a significant effect in favour of the intervention group (risk ratio (RR) 1.55, 95% CI 1.30 to 1.85, <i>low quality of evidence</i>) (<a href="./references#CD011255-fig-0005" title="">Analysis 1.1</a>). Because there was only limited statistical heterogeneity for this outcome (I<sup>2</sup> = 30%) we also pooled the effects by using a fixed‐effect model (RR 1.55, 95% CI 1.35 to 1.79). However, we believe the use of a random‐effects model is more appropriate because of the small clinical differences between the products that were used in the intervention groups. </p> <p>In the sensitivity analysis we excluded the trials with high, or unclear risk of bias for two of the following three domains, namely: generation of the allocation sequence, concealment of allocation and blinding of outcome assessor. Pooling the results from the six trials (<a href="./references#CD011255-bbs2-0002" title="CaravaggiC , DeGiglioR , PritelliC , SommariaM , Dalla NoceS , et al. HYAFF 11‐based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care2003;26(10):2853‐9. ">Caravaggi 2003</a>; <a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>) that were assessed at low risk of bias showed similar results in favour of the intervention group (RR 1.49, 95% CI 1.21 to 1.85;) (<a href="./references#CD011255-fig-0006" title="">Analysis 1.2</a>). </p> <p>Four studies compared two grafts or tissue replacements and reported on incidence of complete closure (<a href="./references#CD011255-bbs2-0003" title="DiDomenicoL , EmchKJ , LandsmanAR , LandsmanA . A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute. Wounds2011;23(7):184‐9. ">DiDomenico 2011</a>; <a href="./references#CD011255-bbs2-0006" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;23(3):149‐56. LandsmanA , RoukisTS , DeFronzoDJ , AgnewP , PetrantoRD , SuprenantM . Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers. Wounds2008;20(5):111‐6. ">Landsman 2008</a>; <a href="./references#CD011255-bbs2-0010" title="PuttirutvongP . Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand2004;87(1):66‐72. ">Puttirutvong 2004</a>; <a href="./references#CD011255-bbs2-0012" title="SandersL , LandsmanAD , LandsmanA , KellerN , CookJ , HopsonM . A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft. Ostomy Wound Management2014;60(8):26‐38. ">Sanders 2014</a>). One of these four studies compared a meshed skin graft with a split‐skin graft in 80 participants (<a href="./references#CD011255-bbs2-0010" title="PuttirutvongP . Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand2004;87(1):66‐72. ">Puttirutvong 2004</a>). Incidence of complete ulcer closure was not specifically stated as an outcome parameter, but trialists reported that all wounds were healed after six months (<a href="./references#CD011255-fig-0010" title="">Analysis 2.1</a>). </p> <p><a href="./references#CD011255-bbs2-0006" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;23(3):149‐56. LandsmanA , RoukisTS , DeFronzoDJ , AgnewP , PetrantoRD , SuprenantM . Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers. Wounds2008;20(5):111‐6. ">Landsman 2008</a> compared a living skin equivalent (Dermagraft®) with an extracellular collagen wound dressing (OASIS®). In this trial no significant differences were found as to the incidence of complete ulcer closure (RR 1.10, 95% CI 0.75 to 1.60) (<a href="./references#CD011255-fig-0011" title="">Analysis 3.1</a>). </p> <p>One study (<a href="./references#CD011255-bbs2-0003" title="DiDomenicoL , EmchKJ , LandsmanAR , LandsmanA . A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute. Wounds2011;23(7):184‐9. ">DiDomenico 2011</a>) reported a higher incidence of ulcer healing after 20 weeks in the TheraSkin® group (66.7%) compared with the Apligraf® group (46.1%), although this difference was not statistically significant (RR 0.71, 95% CI 0.37 to 1.34) (<a href="./references#CD011255-fig-0012" title="">Analysis 4.1</a>). </p> <p><a href="./references#CD011255-bbs2-0012" title="SandersL , LandsmanAD , LandsmanA , KellerN , CookJ , HopsonM . A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft. Ostomy Wound Management2014;60(8):26‐38. ">Sanders 2014</a> reported a higher incidence of ulcer healing after 12 weeks in the TheraSkin® group (63.6%) compared with the Dermagraft® group (33.3%), but this difference was not statistically significant (RR 1.91, 95% CI 0.76 to 4.77) (<a href="./references#CD011255-fig-0013" title="">Analysis 5.1</a>). </p> </section> <section id="CD011255-sec-0082"> <h5 class="title">Time to complete closure of the foot ulcer</h5> <p>Sixteen studies reported on time to complete healing. <a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a> was the only study that did not report on time to complete closure. However, the majority of studies had not been using survival analysis and reported hazard ratios, so meta‐analysis was not possible for this outcome. </p> <p><a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a> was the only study that reported the estimated hazard ratio (HR) for time to complete healing after two weeks. Trialists reported a HR of 2.17 of achieving complete closure per week in favour of the intervention group. </p> <p>We reported all other statements on this outcome in the <a href="./references#CD011255-sec-0142" title="">Characteristics of included studies</a> tables. </p> </section> <section id="CD011255-sec-0083"> <h5 class="title">Total incidence of lower limb amputations</h5> <p>Only two studies reported on the total incidence of amputations. <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a> reported a lower amputation rate after 12 weeks in the Graftskin® group (6.3%) compared with the control group (15.6%). <a href="./references#CD011255-bbs2-0045" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28(1):17‐20. ">Frykberg 2015</a> (the same study as <a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>) reported a lower total number of amputations and bone resections in the Dermagraft group (5.5%) compared with the control group (12.6%). However, when we excluded the bone resections and define 'lower limb amputation' as a below knee amputation, foot amputation or toe amputation, there was no statistical significant difference (3.7% and 7.9%, respectively). By pooling the results of these two studies, we still found that there were fewer lower limb amputations after 12 weeks in the experimental groups; this is a small but statistically significant difference (RR 0.43, 95% CI 0.23 to 0.81, <i>very low quality of evidence</i>) (<a href="./references#CD011255-fig-0007" title="">Analysis 1.3</a>). </p> <p><a href="./references#CD011255-bbs2-0011" title="ReyzelmanA , CrewsRT , MooreJC , MooreL , MukkerJS , OffuttS , et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal2009;6(3):196‐208. ">Reyzelman 2009</a> and <a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a> reported on three amputations as being an adverse event, but it is not clear whether all amputations were reported so these studies were not included in the meta‐analysis. <a href="./references#CD011255-bbs2-0011" title="ReyzelmanA , CrewsRT , MooreJC , MooreL , MukkerJS , OffuttS , et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. International Wound Journal2009;6(3):196‐208. ">Reyzelman 2009</a> stated that two hallux amputations occurred during the study period, but it was not clear to which group these patients were allocated. Edmonds reported one transmetatarsal amputation in the group that was not treated with a tissue replacement. </p> </section> </section> <section id="CD011255-sec-0084"> <h4 class="title">Secondary outcomes</h4> <section id="CD011255-sec-0085"> <h5 class="title">Recurrence rate of foot ulcers</h5> <p>Six studies reported on recurrence rates of foot ulcers (<a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0010" title="PuttirutvongP . Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand2004;87(1):66‐72. ">Puttirutvong 2004</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>; <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>). Four of these studies found no differences in ulcer recurrence rates between the study groups (<a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>; <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>). <a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a> reported one recurrent ulcer in the Apligraf® group (1/15, 7.0%) and one recurrent ulcer in the control group (1/10, 10%). <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a> reported a recurrence percentage of 5.9% in the Graftskin® group (3/112) and 12.9% in the control group (4/96) during the first six months. <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a> showed an ulcer recurrence rate of 6.3% in the intervention group (1/16) and 6.7% in the control group (1/15) among patients who were monitored for 6 months. <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a> reported that none of the healed ulcers (n = 11 intervention group, n = 1 control group) had recurred during the follow‐up period (mean 14 months, range two to 22 months). Pooling of the results of these four studies showed no statistically significant difference in recurrence rates between intervention and control groups (RR 0.69, 95% CI 0.22 to 2.22) (<a href="./references#CD011255-fig-0008" title="">Analysis 1.4</a>). </p> <p><a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a> did not report exact numbers of recurred ulcers, but stated “whereas ulcers recurred in a comparable minority of both groups, it is noteworthy that Dermagraft® tended to delay recurrence (median time to recurrence: 12 weeks for Dermagraft® versus 7 weeks for control)”. </p> <p>One study that compared two grafts reported on ulcer recurrence. <a href="./references#CD011255-bbs2-0010" title="PuttirutvongP . Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage. Journal of the Medical Association of Thailand2004;87(1):66‐72. ">Puttirutvong 2004</a> reported one recurrent ulcer in the split‐skin group and no recurrence in the meshed skin group after six months. </p> </section> <section id="CD011255-sec-0086"> <h5 class="title">Change in ulcer area</h5> <p>Nine studies reported on change or reduction in ulcer area in various ways, which precluded meta‐analysis (<a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-Brigido-2006" target="_blank">Brigido 2006</a>;<a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-Caravaggi-2003" target="_blank">Caravaggi 2003</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-Gentzkow-1996" target="_blank">Gentzkow 1996</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-Marston-2003" target="_blank">Marston 2003</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-Reyzelman-2009" target="_blank">Reyzelman 2009</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-Uccioli-2011" target="_blank">Uccioli 2011</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-You-2012" target="_blank">You 2012</a>; <a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-Zelen-2013" target="_blank">Zelen 2013</a>). </p> <p>Without presenting the exact numbers, <a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-Brigido-2006" target="_blank">Brigido 2006</a> did show a figure of the average percentage of wound area that healed each week. </p> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-Caravaggi-2003" target="_blank">Caravaggi 2003</a> reported the mean percentage in wound size reduction for the ulcers that did not heal during the study period. The mean percentage wound reduction in the intervention group was 61.1% (SD 26.0) for plantar ulcers and 68.0% (SD 37.3) for dorsal ulcers. In the control group these percentages were 64.7% (SD 34.7) and 32.9% (SD 35.1) respectively. </p> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-Gentzkow-1996" target="_blank">Gentzkow 1996</a> reported on percentage of wounds achieving 50% closure after 12 weeks. In the group that received one piece of Dermagraft® weekly for a total of eight pieces and eight applications, 75% of patients achieved 50% wound closure. In the control group 23.1% achieved 50% closure by week 12. </p> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-Marston-2003" target="_blank">Marston 2003</a> reported on the median percentage of wound closure by week 12. They found a median percent wound closure of 91% in the Dermagraft® group and 78% in the control group. </p> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-Reyzelman-2009" target="_blank">Reyzelman 2009</a> reported on the percentage of wounds that decreased in ulcer size but did not heal within 12 weeks. They reported that 85.7% of the patients in the intervention group and 71.4% in the control group experienced a decrease in ulcer size. </p> <p>One study reported on a weekly ulcer size reduction percentage after two weeks (<a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-Uccioli-2011" target="_blank">Uccioli 2011</a>). They reported a weekly reduction percentage of 29% in the intervention group and 14% in the control group. </p> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-You-2012" target="_blank">You 2012</a> reported the mean percentage in wound area reduction for all wounds, including the healed ones. They reported a mean wound size reduction of 87% (SD 49%) in the intervention group and 74% (SD 67%) in the control group in their intention‐to‐treat analysis. </p> <p><a href="./references#CD011255-bbs2-0016" title="YouHJ , HanSK , RhieJW . Randomised controlled clinical trial for autologous fibroblast‐hyaluronic acid complex in treating diabetic foot ulcers. Journal of Wound Care2014;23(11):521‐30. ">You 2014</a> reported on the mean overall wound size reduction compared to the baseline size. In the intervention group they reported 3.0 cm<sup>2</sup> (SD 2.6) wound size reduction and 2.1 cm<sup>2</sup> (SD 1.5) in the control group. </p> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z1506021539038127571014159492841%26format=REVMAN#STD-Zelen-2013" target="_blank">Zelen 2013</a> reported on the average ulcer surface area reduction. After 6 weeks they reported an average reduction of ‐1.8% (SD 70.3) in the control group and 98.4% (SD 5.8) in the intervention group. </p> </section> <section id="CD011255-sec-0087"> <h5 class="title">Incidence of infection</h5> <p>In general, the incidence of infection was poorly reported as a separate outcome. Nine of the studies that compared a skin graft or tissue replacement mentioned ulcer‐related infections (e.g. incidence of wound infection, osteomyelitis or cellulitis) (<a href="./references#CD011255-bbs2-0001" title="BrigidoSA . The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot study. International Wound Journal2006;3(3):181‐7. ">Brigido 2006</a>; <a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>; <a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>; <a href="./references#CD011255-bbs2-0009" title="NaughtonG , MansbridgeJ , GentzkowG . A metabolically active human dermal replacement for the treatment of diabetic foot ulcer. Artificial Organs1997;21(11):1203‐10. PollakRA , EdingtonH , JensenJL , KroekerRO , GentzkowGD . A human dermal replacement for the treatment of diabetic foot ulcers. Wounds1997;9:175‐83. ">Naughton 1997</a>; <a href="./references#CD011255-bbs2-0013" title="UccioliL , GiuratoL , RuotoloV , CiavarellaA , GrimaldiMS , PiaggesiA , et al. Two‐step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long‐term follow‐up. The International Journal of Lower Extremity Wounds2011;10(2):80‐5. ">Uccioli 2011</a>; <a href="./references#CD011255-bbs2-0014" title="VevesA , FalangaV , ArmstrongDG , SabolinskiML . Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care2001;24(2):290‐5. ">Veves 2001</a>; <a href="./references#CD011255-bbs2-0015" title="YouHJ , HanSK , Lee , JW , ChangH . Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes‐‐a pilot study. Wound Repair and Regeneration2012;20(4):491‐9. ">You 2012</a>; <a href="./references#CD011255-bbs2-0017" title="ZelenCM , SerenaTE , DenoziereG , FetterolfDE . A prospective, randomised comparative parallel study amniotic membrane wound graft in the management of diabetic foot ulcers. International Wound Journal2013;10(5):502‐7. ">Zelen 2013</a>). We included these studies and meta‐analysis showed less infections in the intervention group (RR 0.82, 95% CI 0.53 to 0.98) (<a href="./references#CD011255-fig-0009" title="">Analysis 1.5</a>). </p> <p><a href="./references#CD011255-bbs2-0003" title="DiDomenicoL , EmchKJ , LandsmanAR , LandsmanA . A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute. Wounds2011;23(7):184‐9. ">DiDomenico 2011</a> reported the total number of adverse events without exact numbers of patients with infection or an increase in wound size. The exact number of infections was therefore unknown. </p> </section> <section id="CD011255-sec-0088"> <h5 class="title">Quality of life</h5> <p>None of the included studies reported on this outcome.</p> </section> <section id="CD011255-sec-0089"> <h5 class="title">Safety/adverse events</h5> <p><a href="./references#CD011255-bbs2-0006" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;23(3):149‐56. LandsmanA , RoukisTS , DeFronzoDJ , AgnewP , PetrantoRD , SuprenantM . Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers. Wounds2008;20(5):111‐6. ">Landsman 2008</a> was the only study not to report on adverse events. The sixteen other trials mentioned adverse events in various ways. Some studies stated that there were no adverse events (<a href="./references#CD011255-bbs2-0005" title="GentzkowGD , IwasakiSD , HershonKS , MengelM , PrendergastJJ , RicottaJJ , et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care1996;19(4):350‐4. ">Gentzkow 1996</a>; <a href="./references#CD011255-bbs2-0007" title="LipkinS , ChaikofE , IsseroffZ , SilversteinP . Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers. Wounds2003;15(7):230‐6. ">Lipkin 2003</a>), while <a href="./references#CD011255-bbs2-0008" title="FrykbergRG , MarstonWA , CardinalM . The incidence of lower‐extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast‐derived dermal substitute. Advances in Skin &amp; Wound Care2015;28:17‐20. MarstonWA , HanftJ , NorwoodP , PollakR . The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care2003;26(6):1701‐5. ">Marston 2003</a>, for example, reported up to 73% adverse events in the control group. One trial reported a fatal adverse event (myocardial infarction) in the intervention which was unrelated to the study treatment (<a href="./references#CD011255-bbs2-0004" title="EdmondsM , the European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. The International Journal of Lower Extremity Wounds2009;8(1):11‐8. ">Edmonds 2009</a>). No study reported a statistical difference in the occurrence of adverse events between the intervention and the control group. </p> </section> <section id="CD011255-sec-0090"> <h5 class="title">Costs of treatment</h5> <p>Only one study included a comparison of costs (<a href="./references#CD011255-bbs2-0006" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;23(3):149‐56. LandsmanA , RoukisTS , DeFronzoDJ , AgnewP , PetrantoRD , SuprenantM . Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers. Wounds2008;20(5):111‐6. ">Landsman 2008</a>). A separate cost‐effectiveness analysis of this clinical trial is published by <a href="./references#CD011255-bbs2-0047" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;24(3):149‐56. ">Gilligan 2015</a>. Trialists estimated the total costs for the treatment by multiplying the average number of dressings necessary for complete healing and the costs per dressings. On average, treatment with Dermagraft® (total USD 3505; USD 1380 per dressing) was four times more expensive than treatment with OASIS® (total USD 807; USD 125 per dressing). In the cost‐effectiveness analysis, the predicted 12‐week cost per diabetic foot ulcer was USD 2522 for OASIS® and USD 3889 for treatment with Dermagraft® (<a href="./references#CD011255-bbs2-0047" title="GilliganAM , WaycasterCR , LandsmanAL . Wound closure in patients with DFU: a cost‐effectiveness analysis of two cellular/tissue‐derived products. Journal of Wound Care2015;24(3):149‐56. ">Gilligan 2015</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011255-sec-0091" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011255-sec-0091"></div> <section id="CD011255-sec-0092"> <h3 class="title" id="CD011255-sec-0092">Summary of main results</h3> <p>This Cochrane systematic review for skin grafting and tissue replacements for treating foot ulcers in people with diabetes included seventeen RCTs that randomised 1655 participants. Most studies were multicentred (13/17) and were undertaken in the United States (11/17). Risk of bias was variable among studies. For the outcome 'incidence of complete closure of the ulcer' quality of evidence was low and for 'total incidence of lower limb amputations' quality of evidence was very low. Most trials lacked blinding of participants, personnel and outcome assessment because of obvious differences between the treatment strategies. Furthermore, nearly all studies (15/17) reported industry involvement, while at least one of the authors was connected to a commercial organisation or the study was funded by a commercial organisation. Possible publication bias was present because the funnel plot for assessing risk of bias appeared to be asymmetrical; suggesting that small studies with 'negative' results are less likely to be published. </p> <p>Of the included trials in this review, thirteen studies compared a skin graft or tissue replacement with standard care. Four studies compared two grafts or tissue replacements with each other. When pooling the results of all individual studies the skin grafts and tissue replacement products that were used in the trials increased the healing rate of foot ulcers in patients with diabetes compared to standard care (RR 1.55, 95% CI 1.30 to 1.85). Based on the four included studies that directly compared two products, no specific type of skin graft or tissue replacement showed a superior effect on ulcer healing over another type of skin graft or tissue replacement. No statistically significant differences were found for ‘ulcer recurrence’ and ‘incidence of infection’. </p> <p>Sixteen of the included studies reported on adverse events in various ways. Adverse event rates varied widely. No study reported a statistically significant difference in the occurrence of adverse events between the intervention and the control group. </p> <p>Only two of the included studies reported on total incidence of lower limb amputations. Pooling the results of these two studies, we found fewer amputations in the experimental group compared with the standard care group, although the absolute risk reduction for amputation is small (RR 0.43, 95% CI 0.23 to 0.81; RD ‐0.06, 95% CI ‐0.10 to ‐0.01). </p> </section> <section id="CD011255-sec-0093"> <h3 class="title" id="CD011255-sec-0093">Overall completeness and applicability of evidence</h3> <p>Most included trials focused on wound healing speed or reduction in wound size. These seem relevant endpoints, but these data should be interpreted with caution. When wound size reduction is presented in percentages, e.g. 10% after 12 weeks, the clinical relevance for the patient is at best unclear. </p> <p>Not all studies provided sufficient information about baseline characteristics. Baseline information is not only useful to check for baseline imbalances, but it also allows for comparison with other studies. </p> <p>The ultimate goal of treating foot ulcers in people with diabetes is the prevention of (lower) limb amputations. Long‐term follow‐up is therefore not only necessary to assess the potential beneficial effect of these products on healing rates and ulcer recurrence, but also to evaluate amputation rates. Furthermore, no cost information on skin grafts or tissue replacement products was available in the selected trials; it is likely that these products are more expensive than current treatment alternatives and this difference should be taken into account when deciding the treatment strategy. </p> <p>Currently, conventional (or standard) therapy remains the mainstay in the treatment of foot ulcers in people with diabetes. This multidisciplinary approach consists of pressure off‐loading (keeping weight off the area; <a href="./references#CD011255-bbs2-0060" title="LewisJ , LippA . Pressure‐relieving interventions for treating diabetic foot ulcers. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD002302.pub2] ">Lewis 2013</a>), debridement (removal of dead tissue; <a href="./references#CD011255-bbs2-0041" title="EdwardsJ , StapleyS . Debridement of diabetic foot ulcers. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD003556.pub2] ">Edwards 2010</a>), infection control, the use of wound dressings or topical agents (<a href="./references#CD011255-bbs2-0032" title="BerginS , WraightP . Silver based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD005082.pub2] ">Bergin 2006</a>; <a href="./references#CD011255-bbs2-0037" title="DumvilleJC , O'MearaS , DeshpandeS , SpeakK . Alginate dressings for healing diabetic foot ulcers. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009110.pub3] ">Dumville 2013a</a>; <a href="./references#CD011255-bbs2-0038" title="DumvilleJC , DeshpandeS , O'MearaS , SpeakK . Foam dressings for healing diabetic foot ulcers. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009111.pub3] ">Dumville 2013b</a>; <a href="./references#CD011255-bbs2-0039" title="DumvilleJC , O'MearaS , DeshpandeS , SpeakK . Hydrogel dressings for healing diabetic foot ulcers. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD009101.pub3] ">Dumville 2013c</a>; <a href="./references#CD011255-bbs2-0040" title="DumvilleJC , DeshpandeS , O'MearaS , SpeakK . Hydrocolloid dressings for healing diabetic foot ulcers. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD009099.pub3] ">Dumville 2013d</a>; <a href="./references#CD011255-bbs2-0055" title="JullAB , WalkerN , DeshpandeS . Honey as a topical treatment for wounds. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD005083.pub3] ">Jull 2013</a>), intensive regulation of blood glucose (<a href="./references#CD011255-bbs2-0044" title="FernandoME , SeneviratneRM , CunninghamM , LazzariniPA , SanglaKS , Mong TangY , et al. Intensive versus conventional glycaemic control for treating diabetic foot ulcers. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD010764] ">Fernando 2013</a>), and ‐ in the case of ischaemia ‐ vascular reconstruction (<a href="./references#CD011255-bbs2-0043" title="FalangaV . Wound healing and its impairment in the diabetic foot. Lancet2005;366(9498):1736‐43. ">Falanga 2005</a>). However, due to the variety in treatment modalities, treatment intensity and patient adherence, it is likely that there are differences in the effectiveness of standard care as well. This hampers comparing the effectiveness of skin grafts and tissue replacements with standard care. Furthermore, the majority of the included studies only included non‐infected ulcers with an adequate arterial perfusion of the foot, which affects how generalisable the results are. </p> </section> <section id="CD011255-sec-0094"> <h3 class="title" id="CD011255-sec-0094">Quality of the evidence</h3> <p>GRADE assessments were conducted for the three key outcomes. Quality of the evidence was low for the outcome 'incidence of complete closure of the ulcer' and very low for the outcome 'total incidence of lower limb amputations'. For the outcome 'time to complete closure of the ulcer', quality assessment was not possible. Overall, quality of the evidence was downgraded because of risk of bias (lack of blinding, industry involvement and possible publication bias) and imprecision. See <a href="./full#CD011255-tbl-0001">summary of findings Table for the main comparison</a> for a complete assessment and rationale for ratings. </p> <p>We judged some studies to be at ‘unclear risk of bias’ due to the lack of information concerning the methodology stated in the paper. None of the trials used reporting guidelines, e.g. the CONSORT statement (<a href="./references#CD011255-bbs2-0068" title="SchultzKF , AltmanDG , MoherD , for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ2010;340:c332. ">Schulz 2010</a>).The lack of a blinded outcome assessor may have caused detection bias when assessing ulcer healing. However, possible detection bias is hard to prevent due to the nature of the skin replacement products we assessed and the fact that they are easily recognisable. Study sizes were generally small, but pooling yielded a positive effect on ulcer healing although some confidence intervals were wide for a number of comparisons (imprecision). </p> </section> <section id="CD011255-sec-0095"> <h3 class="title" id="CD011255-sec-0095">Potential biases in the review process</h3> <p>We believe that this review has included all RCTs currently available in the field of skin grafts or tissue replacements for treating foot ulcers in people with diabetes. In order to minimise bias in the review process, two of the review authors selected studies, extracted the study data and assessed the risk of bias and quality of the evidence independently. </p> <p>In the assessment of publication bias, the funnel plot appeared to be asymmetrical. Small but statistically significant results, suggesting a beneficial effect for an experimental therapy, are more likely to be published. We may therefore have missed unpublished studies that found 'negative' results (<a href="#CD011255-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD011255-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Skin grafts or tissue replacements compared with standard care, outcome: 1.1 Incidence of complete closure of the foot ulcer." data-id="CD011255-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Skin grafts or tissue replacements compared with standard care, outcome: 1.1 Incidence of complete closure of the foot ulcer. </p> </div> </div> </div> </section> <section id="CD011255-sec-0096"> <h3 class="title" id="CD011255-sec-0096">Agreements and disagreements with other studies or reviews</h3> <p>Although some published reviews and meta‐analyses mentioned the possible beneficial effect of skin grafts or tissue replacements, no rigorous quality assessment was provided in their analysis (<a href="./references#CD011255-bbs2-0033" title="BlozikE , SchererM . Skin replacement therapies for diabetic foot ulcers: systematic review and meta‐analysis. Diabetes Care2008;41(4):693‐4. ">Blozik 2008</a>; <a href="./references#CD011255-bbs2-0077" title="TengYJ , LiYP , WangJW , YangKH , ZhangYC , WangYJ , et al. Bioengineered skin in diabetic foot ulcers. Diabetes, Obesity &amp; Metabolism2010;12(4):307‐15. ">Teng 2010</a>). In this review, we also included newer and more relevant trials. Furthermore, single‐centre results of multicentre studies were sometimes included as if they were separate trials with unrelated results. Despite this pooling, and similar to our pooled results, these reviews reported favourable effects of skin substitutes on ulcer healing. <a href="./references#CD011255-bbs2-0033" title="BlozikE , SchererM . Skin replacement therapies for diabetic foot ulcers: systematic review and meta‐analysis. Diabetes Care2008;41(4):693‐4. ">Blozik 2008</a> found a pooled odds ratio of 1.46, 95% CI 1.21 to 1.76, showing a statistically significant difference in favour of the skin replacement products compared with standard care. <a href="./references#CD011255-bbs2-0077" title="TengYJ , LiYP , WangJW , YangKH , ZhangYC , WangYJ , et al. Bioengineered skin in diabetic foot ulcers. Diabetes, Obesity &amp; Metabolism2010;12(4):307‐15. ">Teng 2010</a> reported a pooled odds ratio of 1.88, 95% CI 1.41 to 2.51, also in favour of the skin substitutes. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011255-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/urn:x-wiley:14651858:media:CD011255:CD011255-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_t/tCD011255-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram of the number of records identified, included and excluded, and the reasons for exclusion" data-id="CD011255-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram of the number of records identified, included and excluded, and the reasons for exclusion </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/full#CD011255-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011255-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/urn:x-wiley:14651858:media:CD011255:CD011255-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_t/tCD011255-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011255-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/full#CD011255-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011255-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/urn:x-wiley:14651858:media:CD011255:CD011255-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_t/tCD011255-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011255-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/full#CD011255-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011255-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/urn:x-wiley:14651858:media:CD011255:CD011255-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_t/tCD011255-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Skin grafts or tissue replacements compared with standard care, outcome: 1.1 Incidence of complete closure of the foot ulcer." data-id="CD011255-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Skin grafts or tissue replacements compared with standard care, outcome: 1.1 Incidence of complete closure of the foot ulcer. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/full#CD011255-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011255-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/urn:x-wiley:14651858:media:CD011255:CD011255-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_t/tCD011255-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Skin grafts or tissue replacements compared with standard care, Outcome 1 Incidence of complete closure of the foot ulcer." data-id="CD011255-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Skin grafts or tissue replacements compared with standard care, Outcome 1 Incidence of complete closure of the foot ulcer. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#CD011255-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011255-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/urn:x-wiley:14651858:media:CD011255:CD011255-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_t/tCD011255-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Skin grafts or tissue replacements compared with standard care, Outcome 2 Incidence of compete closure of the foot ulcer ‐ sensitivity analysis." data-id="CD011255-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Skin grafts or tissue replacements compared with standard care, Outcome 2 Incidence of compete closure of the foot ulcer ‐ sensitivity analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#CD011255-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011255-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/urn:x-wiley:14651858:media:CD011255:CD011255-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_t/tCD011255-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Skin grafts or tissue replacements compared with standard care, Outcome 3 Incidence of lower limb amputations." data-id="CD011255-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Skin grafts or tissue replacements compared with standard care, Outcome 3 Incidence of lower limb amputations. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#CD011255-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011255-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/urn:x-wiley:14651858:media:CD011255:CD011255-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_t/tCD011255-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Skin grafts or tissue replacements compared with standard care, Outcome 4 Ulcer recurrence." data-id="CD011255-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Skin grafts or tissue replacements compared with standard care, Outcome 4 Ulcer recurrence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#CD011255-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011255-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/urn:x-wiley:14651858:media:CD011255:CD011255-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_t/tCD011255-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Skin grafts or tissue replacements compared with standard care, Outcome 5 Incidence of infection." data-id="CD011255-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Skin grafts or tissue replacements compared with standard care, Outcome 5 Incidence of infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#CD011255-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011255-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/urn:x-wiley:14651858:media:CD011255:CD011255-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_t/tCD011255-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Meshed skin graft compared with split‐skin graft, Outcome 1 Incidence of complete closure of the foot ulcer." data-id="CD011255-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Meshed skin graft compared with split‐skin graft, Outcome 1 Incidence of complete closure of the foot ulcer. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#CD011255-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011255-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/urn:x-wiley:14651858:media:CD011255:CD011255-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_t/tCD011255-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Dermagraft® compared with OASIS®, Outcome 1 Incidence of complete closure of the foot ulcer." data-id="CD011255-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Dermagraft® compared with OASIS®, Outcome 1 Incidence of complete closure of the foot ulcer. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#CD011255-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011255-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/urn:x-wiley:14651858:media:CD011255:CD011255-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_t/tCD011255-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Apligraf® compared with TheraSkin®, Outcome 1 Incidence of complete closure of the foot ulcer." data-id="CD011255-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Apligraf® compared with TheraSkin®, Outcome 1 Incidence of complete closure of the foot ulcer. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#CD011255-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011255-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/urn:x-wiley:14651858:media:CD011255:CD011255-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_t/tCD011255-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Dermagraft® compared with TheraSkin®, Outcome 1 Incidence of complete closure of the foot ulcer." data-id="CD011255-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Dermagraft® compared with TheraSkin®, Outcome 1 Incidence of complete closure of the foot ulcer. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#CD011255-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/media/CDSR/CD011255/image_n/nCD011255-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011255-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Skin grafts and tissue replacements compared to placebo or standard care for treating foot ulcers in people with diabetes</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Skin grafts and tissue replacements compared to placebo or standard care for treating foot ulcers in people with diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> People with diabetes who have foot ulcers<br/> <b>Intervention:</b> Skin grafts and tissue replacements<br/> <b>Comparison:</b> Standard care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Standard care</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Skin grafts and tissue replacement products</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of complete closure of the ulcer (healing rate)</b> </p> <p>Follow‐up: 6 to 16 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>273 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>423 per 1000</b> (354 to 504) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.55</b> (1.30 to 1.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1472<br/> (13 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded to low quality of evidence due to lack of blinding, industry involvement and possible publication bias. Furthermore we found wide confidence intervals for a number of comparisons (imprecision). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to complete closure of the ulcer</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to compete healing of the ulcer was reported very heterogeneously. The majority of studies did not used survival analysis and reported hazard ratios, so meta‐analysis was not possible for this outcome and grading the quality of the evidence was not applicable </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total incidence of lower limb amputations</p> <p>Follow‐up: 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>109 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>47 per 1000</b> (25 to 89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.43</b> (0.23 – 0.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>522<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Downgraded by three levels because only two studies reported on this outcome (imprecision) and possible publication bias is present. Furthermore, a longer follow‐up period is necessary to estimate the effect more precisely. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; RCT: randomised controlled trial; RR: risk ratio; N/A: not applicable </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Skin grafts and tissue replacements compared to placebo or standard care for treating foot ulcers in people with diabetes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/full#CD011255-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011255-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Skin grafts or tissue replacements compared with standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incidence of complete closure of the foot ulcer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1472</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [1.30, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Apligraf® or Graftskin®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [1.17, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Dermagraft®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>620</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.85, 2.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 EpiFix®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.08 [1.69, 72.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Graftjacket®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.90 [0.97, 3.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Hyalograft 3D®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [1.06, 2.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Kaloderm®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.90, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 OrCel®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.61, 5.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Incidence of compete closure of the foot ulcer ‐ sensitivity analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>614</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [1.21, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Incidence of lower limb amputations <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>522</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.10, ‐0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Graftskin®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.18, ‐0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Dermagraft®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.09, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Ulcer recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.22, 2.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Apligraf® or Graftskin®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>233</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.18, 2.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Dermagraft®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Kaloderm®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.06, 13.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Incidence of infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>845</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.53, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Apligraf® or Graftskin®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>280</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.43, 1.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Dermagraft®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.40, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 EpiFix®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.01, 3.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Graftjacket®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.6 [0.18, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 Hyalograf 3D®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.62, 2.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6 Kaloderm®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.12, 3.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7 OrCel®</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.10, 2.43]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Skin grafts or tissue replacements compared with standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#CD011255-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011255-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Meshed skin graft compared with split‐skin graft</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incidence of complete closure of the foot ulcer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Meshed skin graft compared with split‐skin graft</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#CD011255-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011255-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Dermagraft® compared with OASIS®</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incidence of complete closure of the foot ulcer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Dermagraft® compared with OASIS®</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#CD011255-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011255-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Apligraf® compared with TheraSkin®</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incidence of complete closure of the foot ulcer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Apligraf® compared with TheraSkin®</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#CD011255-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011255-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Dermagraft® compared with TheraSkin®</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incidence of complete closure of the foot ulcer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Dermagraft® compared with TheraSkin®</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011255.pub2/references#CD011255-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011255.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011255-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011255-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011255-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD011255-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ru#CD011255-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD011255-note-0002">繁體中文</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011255-note-0009">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011255\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011255\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011255\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011255\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011255\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xx9QLps0&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011255.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011255.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011255.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011255.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011255.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715421871"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011255.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715421875"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011255.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d86b04dd39374',t:'MTc0MDcxNTQyMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 